BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: EDWARDS FC, TRUELOVE SC. THE COURSE AND PROGNOSIS OF ULCERATIVE COLITIS. Gut 1963;4:299-315. [PMID: 14084741 DOI: 10.1136/gut.4.4.299] [Cited by in Crossref: 425] [Cited by in F6Publishing: 389] [Article Influence: 7.2] [Reference Citation Analysis]
Number Citing Articles
1 S Y, Kedia S, Teja V, Vuyyuru SK, Yadav N, Sahu P, Jain S, Yadav DP, Bopanna S, Mouli VP, Madhu D, Sharma R, Das P, Makharia G, Ahuja V. Thromboembolism is associated with poor prognosis and high mortality in patients with inflammatory bowel disease: A case-control study. Indian J Gastroenterol 2022. [PMID: 36063357 DOI: 10.1007/s12664-021-01237-w] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Sahu P, Jain S, Kedia S, Vuyyuru SK, Sahni P, Sharma R, Panwar R, Das P, Gupta V, Makharia G, Travis S, Ahuja V. Prospective validation of AIIMS index as a predictor of steroid failure in patients with acute severe ulcerative colitis. Indian J Gastroenterol 2022. [PMID: 35474175 DOI: 10.1007/s12664-021-01217-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Mishra S, Ram S, Prasad KK, Sharma AK, Dutta U, Sharma V. SERUM PROCALCITONIN AS A PROGNOSTIC MARKER IN ACUTE SEVERE ULCERATIVE COLITIS: A PROSPECTIVE STUDY. Arq Gastroenterol 2022;59:75-9. [DOI: 10.1590/s0004-2803.202200001-14] [Reference Citation Analysis]
4 Cleveland NK, Torres J, Rubin DT. What Does Disease Progression Look Like in Ulcerative Colitis, and How Might It Be Prevented? Gastroenterology 2022:S0016-5085(22)00077-4. [PMID: 35101421 DOI: 10.1053/j.gastro.2022.01.023] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
5 Shimizu H, Fujii T, Kinoshita K, Kawamoto A, Hibiya S, Takenaka K, Saito E, Nagahori M, Ohtsuka K, Watanabe M, Okamoto R. Intravenous tacrolimus is a superior induction therapy for acute severe ulcerative colitis compared to oral tacrolimus. BMC Gastroenterol 2021;21:494. [PMID: 34949172 DOI: 10.1186/s12876-021-02043-6] [Reference Citation Analysis]
6 Madarame A, Fukuzawa M, Yamauchi Y, Kono S, Sugimoto A, Yamaguchi H, Morise T, Koyama Y, Uchida K, Suguro M, Matsumoto T, Yasuyuki K, Kawai T, Itoi T. Predictive factors of relapse after dose reduction of oral 5-aminosalicylic acid in patients with ulcerative colitis in the remission phase. PLoS One 2021;16:e0255620. [PMID: 34347848 DOI: 10.1371/journal.pone.0255620] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Inflammatory Bowel Disease Group, Chinese Society of Gastroenterology, Chinese Medical Association. Chinese consensus on diagnosis and treatment in inflammatory bowel disease (2018, Beijing). J Dig Dis 2021;22:298-317. [PMID: 33905603 DOI: 10.1111/1751-2980.12994] [Cited by in Crossref: 1] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
8 Schauer C, Avery V, Seleq S, Garg P, Wang MTM, Chieng M, Rowan C, Sekra A, Lane M, Walmsley R. A comparison of intravenous methylprednisolone and hydrocortisone for the treatment of acute inflammatory bowel disease. J Gastroenterol Hepatol 2021. [PMID: 33939853 DOI: 10.1111/jgh.15535] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Iizuka M, Etou T, Shimodaira Y, Hatakeyama T, Sagara S. Cytapheresis re-induces high-rate steroid-free remission in patients with steroid-dependent and steroid-refractory ulcerative colitis. World J Gastroenterol 2021; 27(12): 1194-1212 [PMID: 33828394 DOI: 10.3748/wjg.v27.i12.1194] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Rosiou K, Selinger CP. Acute severe ulcerative colitis: management advice for internal medicine and emergency physicians. Intern Emerg Med 2021;16:1433-42. [PMID: 33754227 DOI: 10.1007/s11739-021-02704-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Talstad I, Gjone E. The Disease Activity of Ulcerative Colitis and Crohn’s Disease. Scandinavian Journal of Gastroenterology 1976;11:403-8. [DOI: 10.1080/00365521.1976.12097125] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 20.0] [Reference Citation Analysis]
12 Li JR, Ling FM, Chen YD, Xu MY, Zhu LR. Treatment of acute severe ulcerative colitis. Shijie Huaren Xiaohua Zazhi 2021; 29(2): 87-92 [DOI: 10.11569/wcjd.v29.i2.87] [Reference Citation Analysis]
13 Suzuki T, Iwamoto K, Nozaki R, Saiki Y, Tanaka M, Fukunaga M, Yamada K. Diffuse large B-cell lymphoma originating from the rectum and diagnosed after rectal perforation during the treatment of ulcerative colitis: a case report. BMC Surg 2021;21:50. [PMID: 33478454 DOI: 10.1186/s12893-021-01060-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Kucharzik T, Dignass AU, Atreya R, Bokemeyer B, Esters P, Herrlinger K, Kannengießer K, Kienle P, Langhorst J, Lügering A, Schreiber S, Stallmach A, Stein J, Sturm A, Teich N, Siegmund B; Collaborators:. Aktualisierte S3-Leitlinie Colitis ulcerosa – Living Guideline. Z Gastroenterol 2020;58:e241-326. [PMID: 33260237 DOI: 10.1055/a-1296-3444] [Cited by in Crossref: 5] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
15 Kucharzik T, Koletzko S, Kannengiesser K, Dignass A. Ulcerative Colitis-Diagnostic and Therapeutic Algorithms.Dtsch Arztebl Int. 2020;117:564-574. [PMID: 33148393 DOI: 10.3238/arztebl.2020.0564] [Cited by in Crossref: 4] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
16 Marcussen H. Anti-colon Antibodies in Ulcerative Colitis. A Clinical Study. Scandinavian Journal of Gastroenterology 1976;11:763-7. [DOI: 10.1080/00365521.1976.12097185] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Kristensen M, Koudahl G, Fischerman K, Jarnum S. High Dose Prednisone Treatment in Severe Ulcerative Colitis. Scandinavian Journal of Gastroenterology 1974;9:177-83. [DOI: 10.1080/00365521.1974.12096812] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
18 Marner I, Friborg S, Simonsen E. Disease Activity and Serum Proteins in Ulcerative Colitis Immunochemical Quantitation. Scandinavian Journal of Gastroenterology 1975;10:537-44. [DOI: 10.1080/00365521.1975.12097008] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 6.5] [Reference Citation Analysis]
19 Bonnevie O, Binder V, Anthonisen P, Riis P. The Prognosis of Ulcerative Colitis. Scandinavian Journal of Gastroenterology 1974;9:81-91. [DOI: 10.1080/00365521.1974.12096795] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 19.5] [Reference Citation Analysis]
20 Kakimoto K, Matsuura M, Fukuchi T, Hongo H, Kimura T, Aoyama N, Okuda Y, Aomatsu K, Kamata N, Yokoyama Y, Mizuno C, Inoue T, Miyazaki T, Nakamura S, Higuchi K, Nakase H. Exploratory Study of the Effectiveness of Granulocyte and Monocyte Adsorptive Apheresis Before Initiation of Steroids in Patients With Active Ulcerative Colitis (EXPECT Study): A Multicenter Prospective Clinical Trial. Crohns Colitis 360 2020;2:otaa073. [PMID: 34192247 DOI: 10.1093/crocol/otaa073] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Kedia S, Ghosh TS, Jain S, Desigamani A, Kumar A, Gupta V, Bopanna S, Yadav DP, Goyal S, Makharia G, Travis SPL, Das B, Ahuja V. Gut microbiome diversity in acute severe colitis is distinct from mild to moderate ulcerative colitis. J Gastroenterol Hepatol 2021;36:731-9. [PMID: 32870508 DOI: 10.1111/jgh.15232] [Cited by in Crossref: 1] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
22 Ma R, Meng R, Zhang X, Sun Z, Lei Y. Correlation between fecal calprotectin, ulcerative colitis endoscopic index of severity and clinical outcome in patients with acute severe colitis. Exp Ther Med 2020;20:1498-504. [PMID: 32765673 DOI: 10.3892/etm.2020.8861] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
23 Rönnblom A, Karlbom U. Acute severe attacks of ulcerative colitis in a population-based cohort: epidemiology, treatment and outcome. Scandinavian Journal of Gastroenterology 2020;55:555-9. [DOI: 10.1080/00365521.2020.1757143] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
24 Syal G, Robbins L, Kashani A, Bonthala N, Feldman E, Fleshner P, Vasiliauskas E, McGovern D, Ha C, Targan S, Melmed GY. Hypoalbuminemia and Bandemia Predict Failure of Infliximab Rescue Therapy in Acute Severe Ulcerative Colitis. Dig Dis Sci 2021;66:199-205. [PMID: 32170473 DOI: 10.1007/s10620-020-06177-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
25 Rubin DT, Ananthakrishnan AN, Siegel CA, Sauer BG, Long MD. ACG Clinical Guideline: Ulcerative Colitis in Adults. Am J Gastroenterol. 2019;114:384-413. [PMID: 30840605 DOI: 10.14309/ajg.0000000000000152] [Cited by in Crossref: 300] [Cited by in F6Publishing: 444] [Article Influence: 100.0] [Reference Citation Analysis]
26 Bengi G, Cıvak M, Akarsu M, Soytürk M, Ellidokuz E, Topalak Ö, Akpınar H. Prevalance of Celiac Disease in Patients with Inflammatory Bowel Disease in Turkish Population. Gastroenterol Res Pract 2019;2019:6272098. [PMID: 31885543 DOI: 10.1155/2019/6272098] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
27 Dong C, Metzger M, Holsbø E, Perduca V, Carbonnel F. Systematic review with meta-analysis: mortality in acute severe ulcerative colitis. Aliment Pharmacol Ther 2020;51:8-33. [DOI: 10.1111/apt.15592] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
28 Brown SR, Fearnhead NS, Faiz OD, Abercrombie JF, Acheson AG, Arnott RG, Clark SK, Clifford S, Davies RJ, Davies MM, Douie WJP, Dunlop MG, Epstein JC, Evans MD, George BD, Guy RJ, Hargest R, Hawthorne AB, Hill J, Hughes GW, Limdi JK, Maxwell-Armstrong CA, O'Connell PR, Pinkney TD, Pipe J, Sagar PM, Singh B, Soop M, Terry H, Torkington J, Verjee A, Walsh CJ, Warusavitarne JH, Williams AB, Williams GL, Wilson RG; ACPGBI IBD Surgery Consensus Collaboration. The Association of Coloproctology of Great Britain and Ireland consensus guidelines in surgery for inflammatory bowel disease. Colorectal Dis. 2018;20 Suppl 8:3-117. [PMID: 30508274 DOI: 10.1111/codi.14448] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 9.0] [Reference Citation Analysis]
29 Fehily SR, Martin FC, Kamm MA. Simple water-based tacrolimus enemas for refractory proctitis. JGH Open 2020;4:561-4. [PMID: 32782938 DOI: 10.1002/jgh3.12280] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
30 Actis GC, Pellicano R, Fagoonee S, Ribaldone DG. History of Inflammatory Bowel Diseases. J Clin Med. 2019;8:1970. [PMID: 31739460 DOI: 10.3390/jcm8111970] [Cited by in Crossref: 31] [Cited by in F6Publishing: 47] [Article Influence: 10.3] [Reference Citation Analysis]
31 Sedano R, Quera R, Simian D, Yarur AJ. An approach to acute severe ulcerative colitis. Expert Rev Gastroenterol Hepatol 2019;13:943-55. [PMID: 31648574 DOI: 10.1080/17474124.2019.1681974] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
32 Kawasaki K, Nakamura S, Esaki M, Kurahara K, Eizuka M, Nuki Y, Kochi S, Fujiwara M, Oshiro Y, Sugai T, Matsumoto T. Clinical usefulness of magnifying colonoscopy for the diagnosis of ulcerative colitis-associated neoplasia. Dig Endosc. 2019;31 Suppl 1:36-42. [PMID: 30994234 DOI: 10.1111/den.13382] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
33 Plumptre I, Knabel D, Tomecki K. Pyoderma Gangrenosum: A Review for the Gastroenterologist. Inflamm Bowel Dis 2018;24:2510-7. [PMID: 29788368 DOI: 10.1093/ibd/izy174] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 7.0] [Reference Citation Analysis]
34 Moore AC, Bressler B. Acute Severe Ulcerative Colitis: The Oxford Criteria No Longer Predict In-Hospital Colectomy Rates. Dig Dis Sci 2020;65:576-80. [PMID: 31093812 DOI: 10.1007/s10620-019-05668-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
35 Salice M, Rizzello F, Calabrese C, Calandrini L, Gionchetti P. A current overview of corticosteroid use in active ulcerative colitis. Expert Rev Gastroenterol Hepatol 2019;13:557-61. [PMID: 30947569 DOI: 10.1080/17474124.2019.1604219] [Cited by in Crossref: 14] [Cited by in F6Publishing: 20] [Article Influence: 4.7] [Reference Citation Analysis]
36 Hoffmann P, Wehling C, Krisam J, Pfeiffenberger J, Belling N, Gauss A. Performance of tacrolimus in hospitalized patients with steroid-refractory acute severe ulcerative colitis. World J Gastroenterol 2019; 25(13): 1603-1617 [PMID: 30983820 DOI: 10.3748/wjg.v25.i13.1603] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
37 Li K, Strauss R, Marano C, Greenbaum LE, Friedman JR, Peyrin-biroulet L, Brodmerkel C, De Hertogh G. A Simplified Definition of Histologic Improvement in Ulcerative Colitis and its Association With Disease Outcomes up to 30 Weeks from Initiation of Therapy: Post Hoc Analysis of Three Clinical Trials. Journal of Crohn's and Colitis 2019;13:1025-35. [DOI: 10.1093/ecco-jcc/jjz022] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
38 Magro F, Gionchetti P, Eliakim R, Ardizzone S, Armuzzi A, Barreiro-de Acosta M, Burisch J, Gecse KB, Hart AL, Hindryckx P. Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders. J Crohns Colitis. 2017;11:649-670. [PMID: 28158501 DOI: 10.1093/ecco-jcc/jjx008] [Cited by in Crossref: 682] [Cited by in F6Publishing: 783] [Article Influence: 170.5] [Reference Citation Analysis]
39 Morilla I, Uzzan M, Laharie D, Cazals-Hatem D, Denost Q, Daniel F, Belleannee G, Bouhnik Y, Wainrib G, Panis Y, Ogier-Denis E, Treton X. Colonic MicroRNA Profiles, Identified by a Deep Learning Algorithm, That Predict Responses to Therapy of Patients With Acute Severe Ulcerative Colitis. Clin Gastroenterol Hepatol. 2019;17:905-913. [PMID: 30223112 DOI: 10.1016/j.cgh.2018.08.068] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 7.0] [Reference Citation Analysis]
40 Jain S, Kedia S, Bopanna S, Sachdev V, Sahni P, Dash NR, Pal S, Vishnubhatla S, Makharia G, Travis SPL, Ahuja V. Faecal Calprotectin and UCEIS Predict Short-term Outcomes in Acute Severe Colitis: Prospective Cohort Study. J Crohns Colitis. 2017;11:1309-1316. [PMID: 29088461 DOI: 10.1093/ecco-jcc/jjx084] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
41 Jain S, Kedia S, Sethi T, Bopanna S, Yadav DP, Goyal S, Padhan R, Venigalla PM, Sahni P, Dash NR, Pal S, Makharia G, Travis SPL, Ahuja V. Predictors of long-term outcomes in patients with acute severe colitis: A northern Indian cohort study. J Gastroenterol Hepatol. 2018;33:615-622. [PMID: 28801987 DOI: 10.1111/jgh.13921] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
42 Walsh E, Chah YW, Chin SM, Lochhead P, Yajnik V, Denmark V, Garber JJ, Khalili H. Clinical Predictors and Natural History of Disease Extension in Patients with Ulcerative Proctitis. Inflamm Bowel Dis 2017;23:2035-41. [PMID: 28922252 DOI: 10.1097/MIB.0000000000001214] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
43 Kedia S, Jain S, Goyal S, Bopanna S, Yadav DP, Sachdev V, Sahni P, Pal S, Dash NR, Makharia G, Travis SPL, Ahuja V. Potential of Fecal Calprotectin as an Objective Marker to Discriminate Hospitalized Patients with Acute Severe Colitis from Outpatients with Less Severe Disease. Dig Dis Sci 2018;63:2747-53. [PMID: 29948556 DOI: 10.1007/s10620-018-5157-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
44 Ribiere S, Leconte M, Chaussade S, Abitbol V. [Acute severe colitis]. Presse Med 2018;47:312-9. [PMID: 29618409 DOI: 10.1016/j.lpm.2018.02.020] [Reference Citation Analysis]
45 Yamamoto-furusho J, Gutiérrez-grobe Y, López-gómez J, Bosques-padilla F, Rocha-ramírez J. The Mexican consensus on the diagnosis and treatment of ulcerative colitis. Revista de Gastroenterología de México (English Edition) 2018;83:144-67. [DOI: 10.1016/j.rgmxen.2018.04.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
46 Yamamoto-furusho J, Gutiérrez-grobe Y, López-gómez J, Bosques-padilla F, Rocha-ramírez J. Consenso mexicano para el diagnóstico y tratamiento de la colitis ulcerosa crónica idiopática. Revista de Gastroenterología de México 2018;83:144-67. [DOI: 10.1016/j.rgmx.2017.08.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
47 Buckell NA. Nonspecific Inflammatory Bowel Disease in Two General Hospitals 1. J R Soc Med 1978;71:413-6. [DOI: 10.1177/014107687807100605] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
48 Gordon IO, Agrawal N, Willis E, Goldblum JR, Lopez R, Allende D, Liu X, Patil DY, Yerian L, El-Khider F, Fiocchi C, Rieder F. Fibrosis in ulcerative colitis is directly linked to severity and chronicity of mucosal inflammation. Aliment Pharmacol Ther 2018;47:922-39. [PMID: 29411405 DOI: 10.1111/apt.14526] [Cited by in Crossref: 62] [Cited by in F6Publishing: 59] [Article Influence: 15.5] [Reference Citation Analysis]
49 Laharie D, Bourreille A, Branche J, Allez M, Bouhnik Y, Filippi J, Zerbib F, Savoye G, Vuitton L, Moreau J, Amiot A, Cosnes J, Ricart E, Dewit O, Lopez-Sanroman A, Fumery M, Carbonnel F, Bommelaer G, Coffin B, Roblin X, van Assche G, Esteve M, Farkkila M, Gisbert JP, Marteau P, Nahon S, de Vos M, Lambert J, Mary JY, Louis E; Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives. Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximab. Gut 2018;67:237-43. [PMID: 28053054 DOI: 10.1136/gutjnl-2016-313060] [Cited by in Crossref: 87] [Cited by in F6Publishing: 75] [Article Influence: 21.8] [Reference Citation Analysis]
50 Jain S, Kedia S, Bopanna S, Yadav DP, Goyal S, Sahni P, Pal S, Dash NR, Makharia G, Travis SPL, Ahuja V. Are Truelove and Witts criteria for diagnosing acute severe colitis relevant for the Indian population? A prospective study. Intest Res 2018;16:69-74. [PMID: 29422800 DOI: 10.5217/ir.2018.16.1.69] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
51 Iizuka M, Etou T, Kumagai M, Matsuoka A, Numata Y, Sagara S. Long-interval Cytapheresis as a Novel Therapeutic Strategy Leading to Dosage Reduction and Discontinuation of Steroids in Steroid-dependent Ulcerative Colitis. Intern Med. 2017;56:2705-2710. [PMID: 28924114 DOI: 10.2169/internalmedicine.8428-16] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
52 Dart RJ, Irving PM. Optimising use of thiopurines in inflammatory bowel disease. Expert Review of Clinical Immunology 2017;13:877-88. [DOI: 10.1080/1744666x.2017.1351298] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
53 Actis GC, Pellicano R. Inflammatory bowel disease: Efficient remission maintenance is crucial for cost containment. World J Gastrointest Pharmacol Ther 2017; 8(2): 114-119 [PMID: 28533920 DOI: 10.4292/wjgpt.v8.i2.114] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
54 Xie T, Zhao C, Ding C, Zhang T, Dai X, Lv T, Li Y, Guo Z, Gong J, Zhu W. Fecal calprotectin as an alternative to ulcerative colitis endoscopic index of severity to predict the response to corticosteroids of acute severe ulcerative colitis: A prospective observational study. Dig Liver Dis. 2017;49:984-990. [PMID: 28539226 DOI: 10.1016/j.dld.2017.04.021] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
55 Sobrado CW, Sobrado LF. MANAGEMENT OF ACUTE SEVERE ULCERATIVE COLITIS: A CLINICAL UPDATE. Arq Bras Cir Dig 2016;29:201-5. [PMID: 27759787 DOI: 10.1590/0102-6720201600030017] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
56 Dart RJ, Samaan MA, Powell N, Irving PM. Vedolizumab: toward a personalized therapy paradigm for people with ulcerative colitis. Clin Exp Gastroenterol 2017;10:57-66. [PMID: 28424557 DOI: 10.2147/CEG.S110547] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
57 Gionchetti P, Rizzello F, Annese V, Armuzzi A, Biancone L, Castiglione F, Comberlato M, Cottone M, Danese S, Daperno M, D'Incà R, Fries W, Kohn A, Orlando A, Papi C, Vecchi M, Ardizzone S; Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD). Use of corticosteroids and immunosuppressive drugs in inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease.Dig Liver Dis. 2017;49:604-617. [PMID: 28254463 DOI: 10.1016/j.dld.2017.01.161] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 5.6] [Reference Citation Analysis]
58 Fornaro R, Caratto E, Caratto M, Sticchi C, Salerno A, Bianchi R, Scabini S, Casaccia M. Surgery of acute severe ulcerative colitis. Subtotal colectomy: when and how to do it? Eur Surg 2017;49:108-12. [DOI: 10.1007/s10353-016-0458-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
59 Fornaro R, Caratto M, Barbruni G, Fornaro F, Salerno A, Giovinazzo D, Sticchi C, Caratto E. Surgical and medical treatment in patients with acute severe ulcerative colitis. J Dig Dis. 2015;16:558-567. [PMID: 26315728 DOI: 10.1111/1751-2980.12278] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
60 Khalili H, Neovius M, Ekbom A, Ludvigsson JF, Askling J, Chan AT, Olen O. Oral Contraceptive Use and Risk of Ulcerative Colitis Progression: A Nationwide Study. Am J Gastroenterol 2016;111:1614-20. [PMID: 27725646 DOI: 10.1038/ajg.2016.464] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
61 Jones FA. Comments on ‘Colitis’. Proceedings of the Royal Society of Medicine 2016;59:369-77. [DOI: 10.1177/003591576605900420] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
62 Hindryckx P, Jairath V, D'Haens G. Acute severe ulcerative colitis: from pathophysiology to clinical management. Nat Rev Gastroenterol Hepatol. 2016;13:654-664. [PMID: 27580687 DOI: 10.1038/nrgastro.2016.116] [Cited by in Crossref: 67] [Cited by in F6Publishing: 64] [Article Influence: 11.2] [Reference Citation Analysis]
63 Holdsworth CD, Dawson AM, Hall EW. Ulcerative Colitis and Cirrhosis of the Liver [ Abridged ]. Proceedings of the Royal Society of Medicine 2016;57:814-5. [DOI: 10.1177/003591576405700921] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
64 Connelly TM, Devane L, Kelly JC, Wrafter P, Messaris E. The 100 classic papers in ulcerative colitis: a bibliometric analysis. Expert Rev Gastroenterol Hepatol 2016;10:1187-95. [PMID: 27531253 DOI: 10.1080/17474124.2016.1216786] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
65 Watkinson G. Ulcerative Colitis. Scott Med J 1970;15:184-94. [DOI: 10.1177/003693307001500505] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
66 Butt JH. Outpatient management of inflammatory bowel disease: Let's keep it as simple as possible. Postgraduate Medicine 2016;92:69-94. [DOI: 10.1080/00325481.1992.11701512] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
67 Lee HS, Yang SK, Soh JS, Lee S, Bae JH, Lee HJ, Park SH, Yang DH, Kim KJ, Ye BD, Byeon JS, Myung SJ, Yoon YS, Yu CS, Kim JH. Short- and Long-Term Outcomes of Acute Severe Ulcerative Colitis in Korea: The 1999-2005 Cohort. Inflamm Bowel Dis 2015;21:1825-31. [PMID: 25985248 DOI: 10.1097/MIB.0000000000000447] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
68 Fron C, Pierry C, Poullenot F, Chabrun E, Subtil C, Capdepont M, Zerbib F, Belleannée G, Laharie D. Endoscopic and histologic response to cyclosporine in ulcerative colitis and their impact on disease outcome: A cohort study. Dig Liver Dis 2016;48:734-9. [PMID: 27052254 DOI: 10.1016/j.dld.2016.03.007] [Reference Citation Analysis]
69 Marín-jiménez I, Nos P, Domènech E, Riestra S, Gisbert JP, Calvet X, Cortés X, Iglesias E, Huguet JM, Taxonera C, Fernández R, Carpio D, Gutiérrez A, Guardiola J, Laria LC, Sicilia B, Bujanda L, Cea-calvo L, Romero C, Rincón Ó, Juliá B, Panés J. Diagnostic Performance of the Simple Clinical Colitis Activity Index Self-Administered Online at Home by Patients With Ulcerative Colitis: CRONICA-UC Study. American Journal of Gastroenterology 2016;111:261-8. [DOI: 10.1038/ajg.2015.403] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 5.3] [Reference Citation Analysis]
70 Clemente V, Aratari A, Papi C, Vernia P. Short term colectomy rate and mortality for severe ulcerative colitis in the last 40 years. Has something changed? Dig Liver Dis 2016;48:371-5. [PMID: 26854257 DOI: 10.1016/j.dld.2015.12.014] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
71 Seah D, De Cruz P. Review article: the practical management of acute severe ulcerative colitis. Aliment Pharmacol Ther. 2016;43:482-513. [PMID: 26725569 DOI: 10.1111/apt.13491] [Cited by in Crossref: 54] [Cited by in F6Publishing: 50] [Article Influence: 9.0] [Reference Citation Analysis]
72 Schmidt KJ, Müller N, Dignass A, Baumgart DC, Lehnert H, Stange EF, Herrlinger KR, Fellermann K, Büning J. Long-term Outcomes in Steroid-refractory Ulcerative Colitis Treated with Tacrolimus Alone or in Combination with Purine Analogues. J Crohns Colitis 2016;10:31-7. [PMID: 26419459 DOI: 10.1093/ecco-jcc/jjv175] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
73 Jani K, Shah A. Laparoscopic total proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis. J Minim Access Surg 2015;11:177-83. [PMID: 26195875 DOI: 10.4103/0972-9941.140212] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
74 Fasen GS, Pandian TK, Pavey ES, Dozois EJ, Boostrom SY. Long-Term Outcome of IPAA in Patients Presenting with Fulminant Ulcerative Colitis: A Matched Cohort Study. World J Surg 2015;39:2590-4. [DOI: 10.1007/s00268-015-3114-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
75 Löwenberg M, Duijvis NW, Ponsioen C, van den Brink GR, Fockens P, D'Haens GR. Length of hospital stay and associated hospital costs with infliximab versus cyclosporine in severe ulcerative colitis. Eur J Gastroenterol Hepatol 2014;26:1240-6. [PMID: 25171024 DOI: 10.1097/MEG.0000000000000187] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
76 Khalif IL, Nanaeva BA, Golovenko AO, Golovenko OV. [Long-term results of medical treatment in patients with a severe attack of ulcerative colitis]. Ter Arkh 2015;87:34-8. [PMID: 25864346 DOI: 10.17116/terarkh201587234-38] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
77 Dignass A, Lindsay JO, Sturm A, Windsor A, Colombel JF, Allez M, d'Haens G, d'Hoore A, Mantzanaris G, Novacek G, Öresland T, Reinisch W, Sans M, Stange E, Vermeire S, Travis S, van Assche G. [Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management (Spanish version)]. Rev Gastroenterol Mex 2015;80:32-73. [PMID: 25769217 DOI: 10.1016/j.rgmx.2014.10.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
78 Miyake N, Ando T, Ishiguro K, Maeda O, Watanabe O, Hirayama Y, Maeda K, Morise K, Matsushita M, Furukawa K, Funasaka K, Nakamura M, Miyahara R, Ohmiya N, Goto H. Azathioprine is essential following cyclosporine for patients with steroid-refractory ulcerative colitis. World J Gastroenterol 2015; 21(1): 254-261 [PMID: 25574099 DOI: 10.3748/wjg.v21.i1.254] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.9] [Reference Citation Analysis]
79 Ventham NT, Kalla R, Kennedy NA, Satsangi J, Arnott ID. Predicting outcomes in acute severe ulcerative colitis. Expert Rev Gastroenterol Hepatol. 2015;9:405-415. [PMID: 25494666 DOI: 10.1586/17474124.2015.992880] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
80 Dignass A, Eliakim R, Magro F, Maaser C, Chowers Y, Geboes K, Mantzaris G, Reinisch W, Colombel JF, Vermeire S, Travis S, Lindsay JO, van Assche G. [Second European evidence-based Consensus on the diagnosis and management of ulcerative colitis Part 1: Definitions and diagnosis (Spanish version)]. Rev Gastroenterol Mex 2014;79:263-89. [PMID: 25487134 DOI: 10.1016/j.rgmx.2014.10.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
81 Kedia S, Ahuja V, Tandon R. Management of acute severe ulcerative colitis. World J Gastrointest Pathophysiol 2014; 5(4): 579-588 [PMID: 25401001 DOI: 10.4291/wjgp.v5.i4.579] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 25] [Article Influence: 3.8] [Reference Citation Analysis]
82 Park MS, Kim DH, Kim DH, Park SJ, Hong SP, Kim TI, Kim WH, Cheon JH. Leukopenia predicts remission in patients with inflammatory bowel disease and Behcet's disease on thiopurine maintenance. Dig Dis Sci 2015;60:195-204. [PMID: 25239495 DOI: 10.1007/s10620-014-3355-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
83 Nelson R, Liao C, Fichera A, Rubin DT, Pekow J. Rescue therapy with cyclosporine or infliximab is not associated with an increased risk for postoperative complications in patients hospitalized for severe steroid-refractory ulcerative colitis. Inflamm Bowel Dis 2014;20:14-20. [PMID: 24297054 DOI: 10.1097/01.MIB.0000437497.07181.05] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 4.4] [Reference Citation Analysis]
84 Bernstein CN, Ng SC, Lakatos PL, Moum B, Loftus EV Jr; Epidemiology and Natural History Task Force of the International Organization of the Study of Inflammatory Bowel Disease. A review of mortality and surgery in ulcerative colitis: milestones of the seriousness of the disease. Inflamm Bowel Dis. 2013;19:2001-2010. [PMID: 23624887 DOI: 10.1097/mib.0b013e318281f3bb] [Cited by in Crossref: 17] [Cited by in F6Publishing: 42] [Article Influence: 2.1] [Reference Citation Analysis]
85 Han W, Xu J, Hu N, Mei Q, Liu M. Early predictors of responses and clinical outcomes of corticosteroid treatment for severe ulcerative colitis. Scandinavian Journal of Gastroenterology 2014;49:424-33. [DOI: 10.3109/00365521.2014.886716] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
86 Monterubbianesi R, Aratari A, Armuzzi A, Daperno M, Biancone L, Cappello M, Annese V, Riegler G, Orlando A, Viscido A. Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: early and late outcome and predictors of colectomy. J Crohns Colitis. 2014;8:852-858. [PMID: 24472490 DOI: 10.1016/j.crohns.2014.01.006] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 5.3] [Reference Citation Analysis]
87 Hare NC, Arnott ID, Satsangi J. Therapeutic options in acute severe ulcerative colitis. Expert Review of Gastroenterology & Hepatology 2014;2:357-70. [DOI: 10.1586/17474124.2.3.357] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
88 Katz S. My treatment approach to the management of ulcerative colitis. Mayo Clin Proc. 2013;88:841-853. [PMID: 23910410 DOI: 10.1016/j.mayocp.2013.05.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
89 Park SK, Yang SK, Ye BD, Kim KJ, Yang DH, Jung KW, Park SH, Kim JW, Byeon JS, Myung SJ, Kim JH. The long-term efficacy of azathioprine in steroid-dependent ulcerative colitis. Scand J Gastroenterol. 2013;48:1386-1393. [PMID: 24164382 DOI: 10.3109/00365521.2013.845908] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
90 Bordeianou L, Maguire L. State-of-the-Art Surgical Approaches to the Treatment of Medically Refractory Ulcerative Colitis. J Gastrointest Surg 2013;17:2013-9. [DOI: 10.1007/s11605-013-2312-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
91 Lynch RW, Lowe D, Protheroe A, Driscoll R, Rhodes JM, Arnott ID. Outcomes of rescue therapy in acute severe ulcerative colitis: data from the United Kingdom inflammatory bowel disease audit. Aliment Pharmacol Ther. 2013;38:935-945. [PMID: 24004000 DOI: 10.1111/apt.12473] [Cited by in Crossref: 76] [Cited by in F6Publishing: 68] [Article Influence: 8.4] [Reference Citation Analysis]
92 Armuzzi A, Biancone L, Daperno M, Coli A, Pugliese D, Annese V, Aratari A, Ardizzone S, Balestrieri P, Bossa F, Cappello M, Castiglione F, Cicala M, Danese S, D’incà R, Dulbecco P, Feliciangeli G, Fries W, Genise S, Gionchetti P, Gozzi S, Kohn A, Lorenzetti R, Milla M, Onali S, Orlando A, Papparella LG, Renna S, Ricci C, Rizzello F, Sostegni R, Guidi L, Papi C. Adalimumab in active ulcerative colitis: A “real-life” observational study. Digestive and Liver Disease 2013;45:738-43. [DOI: 10.1016/j.dld.2013.03.018] [Cited by in Crossref: 44] [Cited by in F6Publishing: 55] [Article Influence: 4.9] [Reference Citation Analysis]
93 Sjöberg M, Magnuson A, Björk J, Benoni C, Almer S, Friis-Liby I, Hertervig E, Olsson M, Karlén P, Eriksson A. Infliximab as rescue therapy in hospitalised patients with steroid-refractory acute ulcerative colitis: a long-term follow-up of 211 Swedish patients. Aliment Pharmacol Ther. 2013;38:377-387. [PMID: 23799948 DOI: 10.1111/apt.12387] [Cited by in Crossref: 61] [Cited by in F6Publishing: 55] [Article Influence: 6.8] [Reference Citation Analysis]
94 Kurosawa M, Nagai H. Accumulation of Mast Cells in the Lesions and Effects of Antiallergic Drugs on the Patients with Inflammatory Bowel Disease. Ulcers 2013;2013:1-7. [DOI: 10.1155/2013/714807] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
95 Hai Y, Hong Y, Wang Q, Liu X, Li D. Lactulose mediates suppression of dextran sulfate sodium-induced colon inflammation. Journal of Medical Colleges of PLA 2013;28:65-79. [DOI: 10.1016/s1000-1948(13)60019-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
96 Zhang Y, Lin L, Xu Y, Lin Y, Jin Y, Zheng C. 1H NMR-based spectroscopy detects metabolic alterations in serum of patients with early-stage ulcerative colitis. Biochem Biophys Res Commun. 2013;433:547-551. [PMID: 23510994 DOI: 10.1016/j.bbrc.2013.03.012] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 2.8] [Reference Citation Analysis]
97 Barnes E, Herfarth H. Clinical features and diagnosis of ulcerative colitis. Advances in the Management of Inflammatory Bowel Disease. Unitec House: Future Medicine Ltd; 2013. pp. 50-66. [DOI: 10.2217/ebo.12.176] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
98 Sjöberg D, Holmström T, Larsson M, Nielsen AL, Holmquist L, Ekbom A, Rönnblom A. Incidence and natural history of ulcerative colitis in the Uppsala Region of Sweden 2005-2009 - results from the IBD cohort of the Uppsala Region (ICURE). J Crohns Colitis 2013;7:e351-7. [PMID: 23491313 DOI: 10.1016/j.crohns.2013.02.006] [Cited by in Crossref: 50] [Cited by in F6Publishing: 55] [Article Influence: 5.6] [Reference Citation Analysis]
99 Powar MP, Martin P, Croft AR, Walsh A, Petersen D, Stevenson ARL, Lumley JW, Stitz RW, Radford-smith GL, Clark DA. Surgical outcomes in steroid refractory acute severe ulcerative colitis: the impact of rescue therapy: Surgical outcomes in acute severe ulcerative colitis. Colorectal Dis 2013;15:374-9. [DOI: 10.1111/j.1463-1318.2012.03188.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
100 Chen X, Zhai X, Shi J, Liu WW, Tao H, Sun X, Kang Z. Lactulose mediates suppression of dextran sodium sulfate-induced colon inflammation by increasing hydrogen production. Dig Dis Sci. 2013;58:1560-1568. [PMID: 23371012 DOI: 10.1007/s10620-013-2563-7] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
101 Jeon HH, Lee HJ, Jang HW, Yoon JY, Jung YS, Park SJ, Hong SP, Kim TI, Kim WH, Cheon JH. Clinical outcomes and predictive factors in oral corticosteroid-refractory active ulcerative colitis. World J Gastroenterol 2013; 19(2): 265-273 [PMID: 23345950 DOI: 10.3748/wjg.v19.i2.265] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
102 Peake ST, Hart AL. Commentary: Predicting response to ciclosporin in acute severe ulcerative colitis. Aliment Pharmacol Ther 2012;36:1095-6; discussion 1096-7. [PMID: 23130766 DOI: 10.1111/apt.12066] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
103 Uchida K, Araki T, Kusunoki M. History of and current issues affecting surgery for pediatric ulcerative colitis. Surg Today 2013;43:1219-31. [PMID: 23203770 DOI: 10.1007/s00595-012-0434-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
104 Rolny P, Vatn M. Cyclosporine in patients with severe steroid refractory ulcerative colitis in the era of infliximab. Review article. Scand J Gastroenterol 2013;48:131-5. [PMID: 23110487 DOI: 10.3109/00365521.2012.733954] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
105 Moore SE, Raval MJ, Phang TP, Bressler B, Brown CJ; Cochrane Colorectal Cancer Group. Surgery for ulcerative colitis: Outcomes in low volume hospitals versus high volume hospitals. Cochrane Database of Systematic Reviews. [DOI: 10.1002/14651858.cd010175] [Reference Citation Analysis]
106 Laharie D, Bourreille A, Branche J, Allez M, Bouhnik Y, Filippi J, Zerbib F, Savoye G, Nachury M, Moreau J. Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial. Lancet. 2012;380:1909-1915. [PMID: 23063316 DOI: 10.1016/s0140-6736(12)61084-8] [Cited by in Crossref: 342] [Cited by in F6Publishing: 321] [Article Influence: 34.2] [Reference Citation Analysis]
107 Dignass A, Eliakim R, Magro F, Maaser C, Chowers Y, Geboes K, Mantzaris G, Reinisch W, Colombel JF, Vermeire S, Travis S, Lindsay JO, Van Assche G. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis. J Crohns Colitis. 2012;6:965-990. [PMID: 23040452 DOI: 10.1016/j.crohns.2012.09.003] [Cited by in Crossref: 539] [Cited by in F6Publishing: 526] [Article Influence: 53.9] [Reference Citation Analysis]
108 Dignass A, Lindsay JO, Sturm A, Windsor A, Colombel JF, Allez M, D'Haens G, D'Hoore A, Mantzaris G, Novacek G, Oresland T, Reinisch W, Sans M, Stange E, Vermeire S, Travis S, Van Assche G. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management. J Crohns Colitis. 2012;6:991-1030. [PMID: 23040451 DOI: 10.1016/j.crohns.2012.09.002] [Cited by in Crossref: 657] [Cited by in F6Publishing: 628] [Article Influence: 65.7] [Reference Citation Analysis]
109 Atreya R, Neumann H, Neurath MF. [Rational treatment of ulcerative colitis--local or systemic therapy? Surgery?]. MMW Fortschr Med 2012;154:76-8. [PMID: 22957389 DOI: 10.1007/s15006-012-0934-1] [Reference Citation Analysis]
110 Dean KE, Hikaka J, Huakau JT, Walmsley RS. Infliximab or cyclosporine for acute severe ulcerative colitis: a retrospective analysis. J Gastroenterol Hepatol. 2012;27:487-492. [PMID: 22098019 DOI: 10.1111/j.1440-1746.2011.06958.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 3.3] [Reference Citation Analysis]
111 Amornyotin S. Abstracts of the 43rd Nordic Gastroenterology Congress. June 12-15, 2012. Reykjavik, Iceland. Scand J Gastroenterol 2012;47 Suppl 1:S14-84. [PMID: 22679915 DOI: 10.3109/00365521.2012.697267] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
112 Katz J, Frank M. Prolonged fever after Infliximab infusion. World J Gastrointest Pharmacol Ther 2012; 3(3): 34-35 [PMID: 22966481 DOI: 10.4292/wjgpt.v3.i3.34] [Cited by in CrossRef: 2] [Article Influence: 0.2] [Reference Citation Analysis]
113 Targownik LE, Singh H, Nugent Z, Bernstein CN. The epidemiology of colectomy in ulcerative colitis: results from a population-based cohort. Am J Gastroenterol. 2012;107:1228-1235. [PMID: 22613902 DOI: 10.1038/ajg.2012.127] [Cited by in Crossref: 179] [Cited by in F6Publishing: 179] [Article Influence: 17.9] [Reference Citation Analysis]
114 Navaneethan U, Shen B. Pros and cons of medical management of ulcerative colitis. Clin Colon Rectal Surg 2010;23:227-38. [PMID: 22131893 DOI: 10.1055/s-0030-1268249] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
115 Tøttrup A, Erichsen R, Sværke C, Laurberg S, Srensen HT. Thirty-day mortality after elective and emergency total colectomy in Danish patients with inflammatory bowel disease: a population-based nationwide cohort study. BMJ Open 2012;2:e000823. [PMID: 22492386 DOI: 10.1136/bmjopen-2012-000823] [Cited by in Crossref: 59] [Cited by in F6Publishing: 63] [Article Influence: 5.9] [Reference Citation Analysis]
116 Kohn A, Fano V, Monterubbianesi R, Davoli M, Marrollo M, Stasi E, Perucci C, Prantera C. Surgical and nonsurgical hospitalization rates and charges for patients with ulcerative colitis in Italy: a 10-year cohort study. Dig Liver Dis. 2012;44:369-374. [PMID: 22197692 DOI: 10.1016/j.dld.2011.11.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
117 Yoon JY, Cheon JH, Park JJ, Hong SP, Kim TI, Kim WH. Clinical outcomes and factors for response prediction after the first course of corticosteroid therapy in patients with active ulcerative colitis. J Gastroenterol Hepatol. 2011;26:1114-1122. [PMID: 21299620 DOI: 10.1111/j.1440-1746.2011.06688.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
118 Chaparro M, Burgueño P, Iglesias E, Panés J, Muñoz F, Bastida G, Castro L, Jiménez C, Mendoza JL, Barreiro-de Acosta M, Gómez Senent S, Gomollón F, Calvet X, García-planella E, Gómez M, Hernández V, Hinojosa J, Mañosa M, Pérez Nyssen O, Gisbert JP. Infliximab salvage therapy after failure of ciclosporin in corticosteroid-refractory ulcerative colitis: a multicentre study: Infliximab after ciclosporin failure in ulcerative colitis. Alimentary Pharmacology & Therapeutics 2012;35:275-83. [DOI: 10.1111/j.1365-2036.2011.04934.x] [Cited by in Crossref: 86] [Cited by in F6Publishing: 73] [Article Influence: 7.8] [Reference Citation Analysis]
119 Bitton A, Buie D, Enns R, Feagan BG, Jones JL, Marshall JK, Whittaker S, Griffiths AM, Panaccione R; Canadian Association of Gastroenterology Severe Ulcerative Colitis Consensus Group. Treatment of hospitalized adult patients with severe ulcerative colitis: Toronto consensus statements. Am J Gastroenterol. 2012;107:179-194; author reply 195. [PMID: 22108451 DOI: 10.1038/ajg.2011.386] [Cited by in Crossref: 106] [Cited by in F6Publishing: 99] [Article Influence: 9.6] [Reference Citation Analysis]
120 Magro F, Rodrigues A, Vieira AI, Portela F, Cremers I, Cotter J, Correia L, Duarte MA, Tavares ML, Lago P, Ministro P, Peixe P, Lopes S, Garcia EB. Review of the disease course among adult ulcerative colitis population-based longitudinal cohorts. Inflamm Bowel Dis. 2012;18:573-583. [PMID: 21793126 DOI: 10.1002/ibd.21815] [Cited by in Crossref: 89] [Cited by in F6Publishing: 86] [Article Influence: 8.1] [Reference Citation Analysis]
121 Langholz E. Current trends in inflammatory bowel disease: the natural history. Therap Adv Gastroenterol. 2010;3:77-86. [PMID: 21180592 DOI: 10.1177/1756283x10361304] [Cited by in Crossref: 52] [Cited by in F6Publishing: 53] [Article Influence: 4.7] [Reference Citation Analysis]
122 Turner D, Griffiths AM. Acute severe ulcerative colitis in children: a systematic review. Inflamm Bowel Dis 2011;17:440-9. [PMID: 20645317 DOI: 10.1002/ibd.21383] [Cited by in Crossref: 70] [Cited by in F6Publishing: 55] [Article Influence: 6.4] [Reference Citation Analysis]
123 Antonelli E, Giuliano V, Casella G, Villanacci V, Baldini V, Baldoni M, Morelli O, Bassotti G. Ultrasonographic assessment of colonic wall in moderate-severe ulcerative colitis: comparison with endoscopic findings. Dig Liver Dis 2011;43:703-6. [PMID: 21482208 DOI: 10.1016/j.dld.2011.02.019] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
124 Hart AL, Ng SC. Review article: the optimal medical management of acute severe ulcerative colitis. Aliment Pharmacol Ther 2010;32:615-27. [PMID: 20626381 DOI: 10.1111/j.1365-2036.2010.04392.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
125 Buchanan J, Wordsworth S, Ahmad T, Perrin A, Vermeire S, Sans M, Taylor J, Jewell D. Managing the long term care of inflammatory bowel disease patients: The cost to European health care providers. J Crohns Colitis 2011;5:301-16. [PMID: 21683300 DOI: 10.1016/j.crohns.2011.02.005] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
126 Turner D, Travis SP, Griffiths AM, Ruemmele FM, Levine A, Benchimol EI, Dubinsky M, Alex G, Baldassano RN, Langer JC. Consensus for managing acute severe ulcerative colitis in children: a systematic review and joint statement from ECCO, ESPGHAN, and the Porto IBD Working Group of ESPGHAN. Am J Gastroenterol. 2011;106:574-588. [PMID: 21224839 DOI: 10.1038/ajg.2010.481] [Cited by in Crossref: 140] [Cited by in F6Publishing: 116] [Article Influence: 12.7] [Reference Citation Analysis]
127 Oh YS, Chung WC, Hwang SS, Lee KM, Paik CN, Cho YS, Lee BI, Choi GY. [The usefulness of Doppler sonography in the assessment of disease activity of ulcerative colitis]. Korean J Gastroenterol 2010;56:346-52. [PMID: 21173557 DOI: 10.4166/kjg.2010.56.6.346] [Reference Citation Analysis]
128 Nath G, Gulati AK, Shukla VK. Role of bacteria in carcinogenesis, with special reference to carcinoma of the gallbladder. World J Gastroenterol 2010; 16(43): 5395-5404 [PMID: 21086555 DOI: 10.3748/wjg.v16.i43.5395] [Cited by in CrossRef: 57] [Cited by in F6Publishing: 45] [Article Influence: 4.8] [Reference Citation Analysis]
129 Sharkey L, Bredin F, Nightingale A, Parkes M. The use of Cyclosporin A in acute steroid-refractory ulcerative colitis: long term outcomes. J Crohns Colitis 2011;5:91-4. [PMID: 21453876 DOI: 10.1016/j.crohns.2010.10.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
130 Melson JE, Giusto D, Kwasny M, Eichenseer P, Jakate S, Keshavarzian A. Histopathology Predictors of Medically Refractory Ulcerative Colitis. Diseases of the Colon & Rectum 2010;53:1280-6. [DOI: 10.1007/dcr.0b013e3181e751df] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
131 Fukata N, Uchida K, Kusuda T, Koyabu M, Miyoshi H, Fukui T, Matsushita M, Nishio A, Tabata Y, Okazaki K. The effective therapy of cyclosporine A with drug delivery system in experimental colitis. Journal of Drug Targeting 2010;19:458-67. [DOI: 10.3109/1061186x.2010.511224] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
132 D’Incà R, Barollo M, Scarpa M, Grillo AR, Brun P, Vettorato MG, Castagliuolo I, Sturniolo GC. Rectal administration of Lactobacillus casei DG modifies flora composition and Toll-like receptor expression in colonic mucosa of patients with mild ulcerative colitis. Dig Dis Sci. 2011;56:1178-1187. [PMID: 20737210 DOI: 10.1007/s10620-010-1384-1] [Cited by in Crossref: 54] [Cited by in F6Publishing: 48] [Article Influence: 4.5] [Reference Citation Analysis]
133 Gustavsson A, Järnerot G, Hertervig E, Friis-Liby I, Blomquist L, Karlén P, Grännö C, Vilien M, Ström M, Verbaan H. Clinical trial: colectomy after rescue therapy in ulcerative colitis - 3-year follow-up of the Swedish-Danish controlled infliximab study. Aliment Pharmacol Ther. 2010;32:984-989. [PMID: 20937043 DOI: 10.1111/j.1365-2036.2010.04435.x] [Cited by in Crossref: 134] [Cited by in F6Publishing: 120] [Article Influence: 11.2] [Reference Citation Analysis]
134 El-Tawil AM. Implications of abnormal pathology in fulminating colitis on the outcome of surgery. Pathophysiology 2011;18:171-4. [PMID: 20692820 DOI: 10.1016/j.pathophys.2010.07.001] [Reference Citation Analysis]
135 Mahadevan U. Medical treatment of ulcerative colitis. Clin Colon Rectal Surg. 2004;17:7-19. [PMID: 20011280 DOI: 10.1055/s-2004-823066] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 2.4] [Reference Citation Analysis]
136 Rönnblom A, Samuelsson SM, Ekbom A. Ulcerative colitis in the county of Uppsala 1945-2007: incidence and clinical characteristics. J Crohns Colitis. 2010;4:532-536. [PMID: 21122556 DOI: 10.1016/j.crohns.2010.03.003] [Cited by in Crossref: 29] [Cited by in F6Publishing: 77] [Article Influence: 2.4] [Reference Citation Analysis]
137 Walch A, Meshkat M, Vogelsang H, Novacek G, Dejaco C, Angelberger S, Mikulits A, Miehsler W, Gangl A, Reinisch W. Long-term outcome in patients with ulcerative colitis treated with intravenous cyclosporine A is determined by previous exposure to thiopurines. J Crohns Colitis. 2010;4:398-404. [PMID: 21122535 DOI: 10.1016/j.crohns.2010.01.001] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 2.3] [Reference Citation Analysis]
138 Ha CY, Newberry RD, Stone CD, Ciorba MA. Patients with late-adult-onset ulcerative colitis have better outcomes than those with early onset disease. Clin Gastroenterol Hepatol 2010;8:682-687.e1. [PMID: 20363368 DOI: 10.1016/j.cgh.2010.03.022] [Cited by in Crossref: 48] [Cited by in F6Publishing: 41] [Article Influence: 4.0] [Reference Citation Analysis]
139 Button LA, Roberts SE, Goldacre MJ, Akbari A, Rodgers SE, Williams JG. Hospitalized prevalence and 5-year mortality for IBD: record linkage study. World J Gastroenterol 2010;16:431-8. [PMID: 20101767 DOI: 10.3748/wjg.v16.i4.431] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
140 Falvey J, Greenwood R, Creed TJ, Smithson J, Sylvester P, Fraser A, Probert CS. Mortality in ulcerative colitis-what should we tell our patients? Three year mortality following admission for the treatment of ulcerative colitis: a 6 year retrospective case review. Frontline Gastroenterol 2010;1:35-41. [PMID: 28839541 DOI: 10.1136/fg.2009.000216] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
141 Flatmark A, Fretheim B, Gjone E. Early Colectomy in Severe Ulcerative Colitis. Scandinavian Journal of Gastroenterology 2010;4:505-10. [DOI: 10.3109/00365526909180641] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
142 Powell-tuck J, Ritchie JK, Lennard-jones JE. The Prognosis of Idiopathic Proctitis. Scandinavian Journal of Gastroenterology 2010;12:727-32. [DOI: 10.3109/00365527709181711] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 3.9] [Reference Citation Analysis]
143 Dinesen LC, Walsh AJ, Protic MN, Heap G, Cummings F, Warren BF, George B, Mortensen NJ, Travis SP. The pattern and outcome of acute severe colitis. J Crohns Colitis. 2010;4:431-437. [PMID: 21122540 DOI: 10.1016/j.crohns.2010.02.001] [Cited by in Crossref: 190] [Cited by in F6Publishing: 188] [Article Influence: 15.8] [Reference Citation Analysis]
144 Button LA, Roberts SE, Goldacre MJ, Akbari A, Rodgers SE, Williams JG. Hospitalized prevalence and 5-year mortality for IBD: Record linkage study. World J Gastroenterol 2010; 16(4): 431-438 [PMID: 20101767 DOI: 10.3748/wjg.v16.i4.431] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 25] [Article Influence: 1.4] [Reference Citation Analysis]
145 Holme O, Thiis-Evensen E, Vatn MH. Treatment of fulminant ulcerative colitis with cyclosporine A. Scand J Gastroenterol 2009;44:1310-4. [PMID: 19891581 DOI: 10.3109/00365520903222673] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
146 Hancock L, Mortensen NJ. How often do IBD patients require resection of their intestine? Inflamm Bowel Dis. 2008;14 Suppl 2:S68-S69. [PMID: 18816762 DOI: 10.1002/ibd.20600] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
147 Casella G, D’Incà R, Oliva L, Daperno M, Saladino V, Zoli G, Annese V, Fries W, Cortellezzi C. Prevalence of celiac disease in inflammatory bowel diseases: An IG-IBD multicentre study. Dig Liver Dis. 2010;42:175-178. [PMID: 19786375 DOI: 10.1016/j.dld.2009.08.005] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 3.6] [Reference Citation Analysis]
148 Bojic D, Radojicic Z, Nedeljkovic-Protic M, Al-Ali M, Jewell DP, Travis SP. Long-term outcome after admission for acute severe ulcerative colitis in Oxford: the 1992-1993 cohort. Inflamm Bowel Dis. 2009;15:823-828. [PMID: 19145641 DOI: 10.1002/ibd.20843] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 3.7] [Reference Citation Analysis]
149 Lam MY, Lee H, Bright R, Korzenik JR, Sands BE. Validation of interactive voice response system administration of the Short Inflammatory Bowel Disease Questionnaire. Inflamm Bowel Dis. 2009;15:599-607. [PMID: 19023897 DOI: 10.1002/ibd.20803] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
150 Axelsson L, Midtvedt T, Bylund-fellenius A. The Role of Intestinal Bacteria, Bacterial Translocation and Endotoxin in Dextran Sodium Sulphate-Induced Colitis in the Mouse. Microbial Ecology in Health and Disease 2009;9:225-37. [DOI: 10.3109/08910609609166463] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
151 Kjeldsen J, De Muckadell OBS. Assessment of Disease Severity and Activity in Inflammatory Bowel Disease. Scandinavian Journal of Gastroenterology 2009;28:1-9. [DOI: 10.3109/00365529309096037] [Cited by in Crossref: 47] [Cited by in F6Publishing: 50] [Article Influence: 3.6] [Reference Citation Analysis]
152 Moum B, Ekbom A, Vatn MH, Aadland E, Sauar J, Lygren I, Schulz T, Stray N, Fausa O. Clinical Course during the 1st Year after Diagnosis in Ulcerative Colitis and Crohn's Disease: Results of a Large, Prospective Population-based Study in Southeastern Norway, 1990-93. Scandinavian Journal of Gastroenterology 2009;32:1005-12. [DOI: 10.3109/00365529709011217] [Cited by in Crossref: 112] [Cited by in F6Publishing: 107] [Article Influence: 8.6] [Reference Citation Analysis]
153 Schumacher G, Sandstedt B, Kollberg B. A Prospective Study of First Attacks of Inflammatory Bowel Disease and Infectious Colitis: Clinical Findings and Early Diagnosis. Scandinavian Journal of Gastroenterology 2009;29:265-74. [DOI: 10.3109/00365529409090475] [Cited by in Crossref: 39] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]
154 De Dombal FT, Room R, Pagliaro L, Lambert R. Report of the OMGE Research Committee. Scandinavian Journal of Gastroenterology 2009;23:9-67. [DOI: 10.3109/00365528809096267] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
155 Schumacher G, Kollberg B, Sandstedt B, Jorup C, Grillner L, Ljungh Å, Möllby R. A Prospective Study of First Attacks of Inflammatory Bowel Disease and Non-Relapsing Colitis: Microbiologic Findings. Scandinavian Journal of Gastroenterology 2009;28:1077-85. [DOI: 10.3109/00365529309098313] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 3.3] [Reference Citation Analysis]
156 Schumacher G, Sandstedt B, Möllby R, Kollberg B. Clinical and Histologic Features Differentiating Non-Relapsing Colitis from First Attacks of Inflammatory Bowel Disease. Scandinavian Journal of Gastroenterology 2009;26:151-61. [DOI: 10.3109/00365529109025025] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
157 Solberg IC, Lygren I, Jahnsen J, Aadland E, Høie O, Cvancarova M, Bernklev T, Henriksen M, Sauar J, Vatn MH. Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study). Scand J Gastroenterol. 2009;44:431-440. [PMID: 19101844 DOI: 10.1080/00365520802600961] [Cited by in Crossref: 440] [Cited by in F6Publishing: 436] [Article Influence: 33.8] [Reference Citation Analysis]
158 Long MD, Plevy SE. Poorly responsive ulcerative colitis in the hospital. Clin Gastroenterol Hepatol 2009;7:635-40. [PMID: 19306946 DOI: 10.1016/j.cgh.2009.03.012] [Reference Citation Analysis]
159 Bossa F, Colombo E, Andriulli A, Annese V. Treatment of steroid-naive ulcerative colitis. Expert Opinion on Pharmacotherapy 2009;10:1449-60. [DOI: 10.1517/14656560902973728] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
160 Anthonisen P, Christoffersen P, Riis P, Schourup K, Schwartz M. Liver Histology in Ulcerative Colitis. Acta Medica Scandinavica 1966;180:551-60. [DOI: 10.1111/j.0954-6820.1966.tb02869.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
161 Ho GT, Lee HM, Brydon G, Ting T, Hare N, Drummond H, Shand AG, Bartolo DC, Wilson RG, Dunlop MG, Arnott ID, Satsangi J. Fecal calprotectin predicts the clinical course of acute severe ulcerative colitis. Am J Gastroenterol 2009;104:673-8. [PMID: 19262524 DOI: 10.1038/ajg.2008.119] [Cited by in Crossref: 97] [Cited by in F6Publishing: 102] [Article Influence: 7.5] [Reference Citation Analysis]
162 Brown SR, Haboubi N, Hampton J, George B, Travis SP. The management of acute severe colitis: ACPGBI position statement. Colorectal Dis. 2008;10 Suppl 3:8-29. [PMID: 18954307 DOI: 10.1111/j.1463-1318.2008.01682.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 2.6] [Reference Citation Analysis]
163 Romberg-Camps MJ, Dagnelie PC, Kester AD, Hesselink-van de Kruijs MA, Cilissen M, Engels LG, Van Deursen C, Hameeteman WH, Wolters FL, Russel MG, Stockbrügger RW. Influence of phenotype at diagnosis and of other potential prognostic factors on the course of inflammatory bowel disease. Am J Gastroenterol 2009;104:371-83. [PMID: 19174787 DOI: 10.1038/ajg.2008.38] [Cited by in Crossref: 202] [Cited by in F6Publishing: 188] [Article Influence: 15.5] [Reference Citation Analysis]
164 Halfvarson J, Järnerot G. Treatment of choice for acute severe steroid-refractory ulcerative colitis is Remicade: . Inflammatory Bowel Diseases 2009;15:143-5. [DOI: 10.1002/ibd.20782] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
165 Ravishankar PG, Velayos FS. Forecasting cyclosporine success or failure. Inflamm Bowel Dis 2009;15:152-3. [PMID: 18465806 DOI: 10.1002/ibd.20503] [Reference Citation Analysis]
166 Treton X, Laharie D. Prise en charge d’une colite aiguë grave. Gastroentérologie Clinique et Biologique 2008;32:1030-7. [DOI: 10.1016/j.gcb.2008.10.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
167 Hancock L, Mortensen NJ. How often do IBD patients require resection of their intestine?: . Inflammatory Bowel Diseases 2008;14:S68-9. [DOI: 10.1097/00054725-200810001-00036] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
168 Assche GV, Vermeire S, Rutgeerts P. Treatment of severe steroid refractory ulcerative colitis. World J Gastroenterol 2008; 14(36): 5508-5511 [PMID: 18810767 DOI: 10.3748/wjg.14.5508] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
169 D'Incà R, Dal Pont E, Di Leo V, Benazzato L, Martinato M, Lamboglia F, Oliva L, Sturniolo GC. Can calprotectin predict relapse risk in inflammatory bowel disease? Am J Gastroenterol 2008;103:2007-14. [PMID: 18802997 DOI: 10.1111/j.1572-0241.2008.01870.x] [Cited by in Crossref: 137] [Cited by in F6Publishing: 132] [Article Influence: 9.8] [Reference Citation Analysis]
170 Rizzello F, Campieri M, Tambasco R, Straforini G, Brugnera R, Poggioli G, Gionchetti P. Medical treatment and management of severe ulcerative colitis. Dig Liver Dis 2008;40 Suppl 2:S280-4. [PMID: 18599001 DOI: 10.1016/S1590-8658(08)60538-1] [Reference Citation Analysis]
171 Lau A, Chande N, Ponich T, Gregor JC. Predictive factors associated with immunosuppressive agent use in ulcerative colitis: a case-control study. Aliment Pharmacol Ther. 2008;28:606-613. [PMID: 18564323 DOI: 10.1111/j.1365-2036.2008.03772.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
172 Danese S, Angelucci E, Malesci A, Caprilli R. Biological agents for ulcerative colitis: hypes and hopes. Med Res Rev. 2008;28:201-218. [PMID: 17464967 DOI: 10.1002/med.20103] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
173 Aceituno M, García-Planella E, Heredia C, Zabana Y, Feu F, Domènech E, Gassull MA, Panés J. Steroid-refractory ulcerative colitis: predictive factors of response to cyclosporine and validation in an independent cohort. Inflamm Bowel Dis 2008;14:347-52. [PMID: 18050296 DOI: 10.1002/ibd.20322] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 2.7] [Reference Citation Analysis]
174 Aratari A, Papi C, Clemente V, Moretti A, Luchetti R, Koch M, Capurso L, Caprilli R. Colectomy rate in acute severe ulcerative colitis in the infliximab era. Dig Liver Dis. 2008;40:821-826. [PMID: 18472316 DOI: 10.1016/j.dld.2008.03.014] [Cited by in Crossref: 115] [Cited by in F6Publishing: 115] [Article Influence: 8.2] [Reference Citation Analysis]
175 Ando T, Nishio Y, Watanabe O, Takahashi H, Maeda O, Ishiguro K, Ishikawa D, Ohmiya N, Niwa Y, Goto H. Value of colonoscopy for prediction of prognosis in patients with ulcerative colitis. World J Gastroenterol 2008; 14(14): 2133-2138 [PMID: 18407585 DOI: 10.3748/wjg.14.2133] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
176 Eason RJ, Lee SP, Tasman-jones C. Inflammatory Bowel Disease in Auckland, New Zealand. Australian and New Zealand Journal of Medicine 1982;12:125-31. [DOI: 10.1111/j.1445-5994.1982.tb02443.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 75] [Article Influence: 2.1] [Reference Citation Analysis]
177 Travis S, Stange E, Lémann M, Øresland T, Bemelman W, Chowers Y, Colombel J, D'haens G, Ghosh S, Marteau P, Kruis W, Mortensen N, Penninckx F, Gassull M. European evidence-based Consensus on the management of ulcerative colitis: Current management. Journal of Crohn's and Colitis 2008;2:24-62. [DOI: 10.1016/j.crohns.2007.11.002] [Cited by in Crossref: 378] [Cited by in F6Publishing: 343] [Article Influence: 27.0] [Reference Citation Analysis]
178 Cacheux W, Seksik P, Lemann M, Marteau P, Nion-Larmurier I, Afchain P, Daniel F, Beaugerie L, Cosnes J. Predictive factors of response to cyclosporine in steroid-refractory ulcerative colitis. Am J Gastroenterol 2008;103:637-42. [PMID: 18047542 DOI: 10.1111/j.1572-0241.2007.01653.x] [Cited by in Crossref: 73] [Cited by in F6Publishing: 58] [Article Influence: 5.2] [Reference Citation Analysis]
179 Stange EF, Travis SP, Vermeire S, Reinisch W, Geboes K, Barakauskiene A, Feakins R, Fléjou JF, Herfarth H, Hommes DW. European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis. J Crohns Colitis. 2008;2:1-23. [PMID: 21172194 DOI: 10.1016/j.crohns.2007.11.001] [Cited by in Crossref: 353] [Cited by in F6Publishing: 333] [Article Influence: 25.2] [Reference Citation Analysis]
180 Zamirian M, Aslani A. Response to Dr. Ze-Zhou Song. Am J Gastroenterol 2008;103:241-241. [DOI: 10.1111/j.1572-0241.2007.01562_2.x] [Reference Citation Analysis]
181 Kohn A, Daperno M, Armuzzi A, Cappello M, Biancone L, Orlando A, Viscido A, Annese V, Riegler G, Meucci G. Infliximab in severe ulcerative colitis: short-term results of different infusion regimens and long-term follow-up. Aliment Pharmacol Ther. 2007;26:747-756. [PMID: 17697208 DOI: 10.1111/j.1365-2036.2007.03415.x] [Cited by in Crossref: 120] [Cited by in F6Publishing: 112] [Article Influence: 8.0] [Reference Citation Analysis]
182 Bianchi Porro G, Cassinotti A, Ferrara E, Maconi G, Ardizzone S. Review article: the management of steroid dependency in ulcerative colitis. Aliment Pharmacol Ther. 2007;26:779-794. [PMID: 17767462 DOI: 10.1111/j.1365-2036.2007.03334.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 2.8] [Reference Citation Analysis]
183 Høie O, Aamodt G, Vermeire S, Bernklev T, Odes S, Wolters FL, Riis L, Politi P, Tsianos EV, Butrón M, Stockbrügger RW, Munkholm P, Vatn M, Moum B; European Collaborative study group of Inflammatory Bowel Disease (EC-IBD). Serological markers are associated with disease course in ulcerative colitis. A study in an unselected population-based cohort followed for 10 years. J Crohns Colitis 2008;2:114-22. [PMID: 21172201 DOI: 10.1016/j.crohns.2007.10.001] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 1.5] [Reference Citation Analysis]
184 Gustavsson A, Halfvarson J, Magnuson A, Sandberg-Gertzén H, Tysk C, Järnerot G. Long-term colectomy rate after intensive intravenous corticosteroid therapy for ulcerative colitis prior to the immunosuppressive treatment era. Am J Gastroenterol 2007;102:2513-9. [PMID: 17680849 DOI: 10.1111/j.1572-0241.2007.01435.x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 3.5] [Reference Citation Analysis]
185 Fleyfel M, Dusson C, Ousmane ML, Guidat A, Colombel JF, Gambiez L, Vallet B. Inflammation affects sufentanil consumption in ulcerative colitis. Eur J Anaesthesiol 2008;25:188-92. [PMID: 17892611 DOI: 10.1017/S0265021507002682] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
186 Plevy S, Salzberg B, Van Assche G, Regueiro M, Hommes D, Sandborn W, Hanauer S, Targan S, Mayer L, Mahadevan U. A phase I study of visilizumab, a humanized anti-CD3 monoclonal antibody, in severe steroid-refractory ulcerative colitis. Gastroenterology. 2007;133:1414-1422. [PMID: 17920064 DOI: 10.1053/j.gastro.2007.08.035] [Cited by in Crossref: 95] [Cited by in F6Publishing: 82] [Article Influence: 6.3] [Reference Citation Analysis]
187 Höie O, Wolters F, Riis L, Aamodt G, Solberg C, Bernklev T, Odes S, Mouzas IA, Beltrami M, Langholz E, Stockbrügger R, Vatn M, Moum B; European Collaborative Study Group of Inflammatory Bowel Disease (EC-IBD). Ulcerative colitis: patient characteristics may predict 10-yr disease recurrence in a European-wide population-based cohort. Am J Gastroenterol 2007;102:1692-701. [PMID: 17555460 DOI: 10.1111/j.1572-0241.2007.01265.x] [Cited by in Crossref: 153] [Cited by in F6Publishing: 147] [Article Influence: 10.2] [Reference Citation Analysis]
188 Park SH, Kim YM, Yang SK, Kim SH, Byeon JS, Myung SJ, Cho YK, Yu CS, Choi KS, Chung JW. Clinical features and natural history of ulcerative colitis in Korea. Inflamm Bowel Dis. 2007;13:278-283. [PMID: 17206722 DOI: 10.1002/ibd.20015] [Cited by in Crossref: 92] [Cited by in F6Publishing: 86] [Article Influence: 6.1] [Reference Citation Analysis]
189 Nash CL, Sutherland LR. Medical management of inflammatory bowel disease: old and new perspectives. Curr Opin Gastroenterol 2001;17:336-41. [PMID: 17031180 DOI: 10.1097/00001574-200107000-00007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
190 Ferrante M, Vermeire S, Katsanos KH, Noman M, Van Assche G, Schnitzler F, Arijs I, De Hertogh G, Hoffman I, Geboes JK. Predictors of early response to infliximab in patients with ulcerative colitis. Inflamm Bowel Dis. 2007;13:123-128. [PMID: 17206703 DOI: 10.1002/ibd.20054] [Cited by in Crossref: 130] [Cited by in F6Publishing: 126] [Article Influence: 8.7] [Reference Citation Analysis]
191 Ando T, Takahashi H, Watanabe O, Maeda O, Ishiguro K, Ishikawa D, Hasegawa M, Ohmiya N, Niwa Y, Goto H. Magnifying chromoscopy, a novel and useful technique for colonoscopy in ulcerative colitis. World J Gastroenterol 2007; 13(18): 2523-2528 [PMID: 17551998 DOI: 10.3748/wjg.v13.i18.2523] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
192 Seksik P, Daniel F, Marteau P, Beaugerie L, Cosnes J. [Refractory proctitis]. Gastroenterol Clin Biol 2007;31:393-7. [PMID: 17483776 DOI: 10.1016/s0399-8320(07)89398-5] [Reference Citation Analysis]
193 Bianchi V, Maconi G, Ardizzone S, Colombo E, Ferrara E, Russo A, Tenchini ML, Porro GB. Association of NOD2/CARD15 mutations on Crohn's disease phenotype in an Italian population. Eur J Gastroenterol Hepatol. 2007;19:217-223. [PMID: 17301648 DOI: 10.1097/01.meg.0000250590.84102.12] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
194 Blomberg B, Järnerot G. Clinical evaluation and management of acute severe colitis. Inflamm Bowel Dis 2000;6:214-27. [DOI: 10.1002/ibd.3780060309] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
195 Ekbom A. Risk factors and distinguishing features of cancer in IBD. Inflamm Bowel Dis 1998;4:235-43. [DOI: 10.1002/ibd.3780040308] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
196 Carbonnel F. Prise en charge d’une rectocolite hémorragique sévère ou corticorésistante. Gastroentérologie Clinique et Biologique 2007;31:398-403. [DOI: 10.1016/s0399-8320(07)89399-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
197 Jess T, Gamborg M, Munkholm P, Sørensen TI. Overall and cause-specific mortality in ulcerative colitis: meta-analysis of population-based inception cohort studies. Am J Gastroenterol 2007;102:609-17. [PMID: 17156150 DOI: 10.1111/j.1572-0241.2006.01000.x] [Cited by in Crossref: 106] [Cited by in F6Publishing: 101] [Article Influence: 7.1] [Reference Citation Analysis]
198 Bossa F, Fiorella S, Caruso N, Accadia L, Napolitano G, Valvano MR, Andriulli A, Annese V. Continuous infusion versus bolus administration of steroids in severe attacks of ulcerative colitis: a randomized, double-blind trial. Am J Gastroenterol 2007;102:601-8. [PMID: 17156148 DOI: 10.1111/j.1572-0241.2006.01007.x] [Cited by in Crossref: 76] [Cited by in F6Publishing: 60] [Article Influence: 5.1] [Reference Citation Analysis]
199 Brady RR, Collie MH, Ho GT, Bartolo DC, Wilson RG, Dunlop MG. Outcomes of the rectal remnant following colectomy for ulcerative colitis. Colorectal Dis. 2008;10:144-150. [PMID: 17302914 DOI: 10.1111/j.1463-1318.2007.01224.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 0.3] [Reference Citation Analysis]
200 Henriksen M, Jahnsen J, Lygren I, Sauar J, Kjellevold Ø, Schulz T, Vatn MH, Moum B. Ulcerative colitis and clinical course: results of a 5-year population-based follow-up study (the IBSEN study). Inflamm Bowel Dis. 2006;12:543-550. [PMID: 16804390 DOI: 10.1097/01.mib.0000225339.91484.fc] [Cited by in Crossref: 187] [Cited by in F6Publishing: 170] [Article Influence: 12.5] [Reference Citation Analysis]
201 Castro M, Papadatou B, Ceriati E, Knafelz D, De Angelis P, Ferretti F, Gambarara M, Diamanti A, De Peppo F, Rivosecchi M. Role of cyclosporin in preventing or delaying colectomy in children with severe ulcerative colitis. Langenbecks Arch Surg 2007;392:161-4. [DOI: 10.1007/s00423-006-0068-y] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
202 Moskovitz DN, Van Assche G, Maenhout B, Arts J, Ferrante M, Vermeire S, Rutgeerts P. Incidence of colectomy during long-term follow-up after cyclosporine-induced remission of severe ulcerative colitis. Clin Gastroenterol Hepatol. 2006;4:760-765. [PMID: 16716758 DOI: 10.1016/j.cgh.2006.04.001] [Cited by in Crossref: 207] [Cited by in F6Publishing: 179] [Article Influence: 12.9] [Reference Citation Analysis]
203 Ding YJ, Yu JP, Luo HS, Zhou ZY, Liu J. Evaluation and analysis of colonoscopy in the diagnosis of 186 cases of ulcerative colitis patients. Int J Clin Pract 2006;60:1408-10. [PMID: 16669833 DOI: 10.1111/j.1742-1241.2005.00781.x] [Reference Citation Analysis]
204 García-López S, Gomollón-García F, Pérez-Gisbert J. Cyclosporine in the treatment of severe attack of ulcerative colitis: a systematic review. Gastroenterol Hepatol. 2005;28:607-614. [PMID: 16373009 DOI: 10.1016/s0210-5705(05)71523-5] [Cited by in Crossref: 54] [Cited by in F6Publishing: 51] [Article Influence: 3.4] [Reference Citation Analysis]
205 Baumgart DC, Pintoffl JP, Sturm A, Wiedenmann B, Dignass AU. Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease--a long-term follow-up. Am J Gastroenterol 2006;101:1048-56. [PMID: 16573777 DOI: 10.1111/j.1572-0241.2006.00524.x] [Cited by in Crossref: 128] [Cited by in F6Publishing: 118] [Article Influence: 8.0] [Reference Citation Analysis]
206 Ardizzone S, Maconi G, Russo A, Imbesi V, Colombo E, Bianchi Porro G. Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis. Gut 2006;55:47-53. [PMID: 15972298 DOI: 10.1136/gut.2005.068809] [Cited by in Crossref: 365] [Cited by in F6Publishing: 338] [Article Influence: 22.8] [Reference Citation Analysis]
207 Pal S, Sahni P, Pande GK, Acharya SK, Chattopadhyay TK. Outcome following emergency surgery for refractory severe ulcerative colitis in a tertiary care centre in India. BMC Gastroenterol. 2005;5:39. [PMID: 16316474 DOI: 10.1186/1471-230x-5-39] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 1.6] [Reference Citation Analysis]
208 Kugathasan S, Dubinsky MC, Keljo D, Moyer MS, Rufo PA, Wyllie R, Zachos M, Hyams J. Severe Colitis in Children: . Journal of Pediatric Gastroenterology and Nutrition 2005;41:375-85. [DOI: 10.1097/01.mpg.0000186272.65559.ce] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
209 Eaden J. Review article: colorectal carcinoma and inflammatory bowel disease. Aliment Pharmacol Ther. 2004;20 Suppl 4:24-30. [PMID: 15352890 DOI: 10.1111/j.1365-2036.2004.02046.x] [Cited by in Crossref: 74] [Cited by in F6Publishing: 66] [Article Influence: 4.4] [Reference Citation Analysis]
210 Boland CR, Luciani MG, Gasche C, Goel A. Infection, inflammation, and gastrointestinal cancer. Gut 2005;54:1321-31. [PMID: 16099799 DOI: 10.1136/gut.2004.060079] [Cited by in Crossref: 67] [Cited by in F6Publishing: 56] [Article Influence: 3.9] [Reference Citation Analysis]
211 Yamamoto T, Umegae S, Kitagawa T, Matsumoto K. Systemic and local cytokine production in quiescent ulcerative colitis and its relationship to future relapse: a prospective pilot study. Inflamm Bowel Dis. 2005;11:589-596. [PMID: 15905707 DOI: 10.1097/01.mib.0000161917.97136.e2] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 2.3] [Reference Citation Analysis]
212 Costello CM, Mah N, Häsler R, Rosenstiel P, Waetzig GH, Hahn A, Lu T, Gurbuz Y, Nikolaus S, Albrecht M, Hampe J, Lucius R, Klöppel G, Eickhoff H, Lehrach H, Lengauer T, Schreiber S. Dissection of the inflammatory bowel disease transcriptome using genome-wide cDNA microarrays. PLoS Med 2005;2:e199. [PMID: 16107186 DOI: 10.1371/journal.pmed.0020199] [Cited by in Crossref: 138] [Cited by in F6Publishing: 152] [Article Influence: 8.1] [Reference Citation Analysis]
213 Guidat A, Fleyfel M, Vallet B, Desreumaux P, Levron JC, Gambiez L, Colombel JF, Scherpereel P. Inflammation increases sufentanil requirements during surgery for inflammatory bowel diseases. Eur J Anaesthesiol 2003;20:957-62. [DOI: 10.1017/s0265021503001546] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
214 Gustot T, Lemmers A, Louis E, Nicaise C, Quertinmont E, Belaiche J, Roland S, Van Gossum A, Devière J, Franchimont D. Profile of soluble cytokine receptors in Crohn's disease. Gut 2005;54:488-95. [PMID: 15753533 DOI: 10.1136/gut.2004.043554] [Cited by in Crossref: 54] [Cited by in F6Publishing: 53] [Article Influence: 3.2] [Reference Citation Analysis]
215 Ando T, Watanabe O, Furuta R, Maeda O, Nishio Y, Nishiwaki T, Ina K, Kusugami K, Goto H. Predictors of a response to cyclosporine or leukocyte removal therapy in patients with refractory ulcerative colitis. Dig Endosc 2005;17:153-8. [DOI: 10.1111/j.1443-1661.2005.00494.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
216 Zhang H, Ouyang Q, Wen ZH, Fiocchi C, Liu WP, Chen DY, Li FY. Significance of glucocorticoid receptor expression in colonic mucosal cells of patients with ulcerative colitis. World J Gastroenterol 2005; 11(12): 1775-1778 [PMID: 15793862 DOI: 10.3748/wjg.v11.i12.1775] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
217 Sicilia B, Vicente R, Arroyo M, Arribas F, Gomollón F. La afectación pancolónica inicial en la colitis ulcerosa predice la necesidad de colectomía: estudio poblacional basado en una cohorte incidente de pacientes en Aragón. Gastroenterología y Hepatología 2005;28:55-9. [DOI: 10.1157/13070700] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
218 Soriano-izquierdo A, Gironella M, Massaguer A, Salas A, Gil F, Piqué JM, Panés J. Effect of Cyclosporin A on Cell Adhesion Molecules and Leukocyte-Endothelial Cell Interactions in Experimental Colitis: . Inflammatory Bowel Diseases 2004;10:789-800. [DOI: 10.1097/00054725-200411000-00014] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
219 Binder V. Epidemiology of IBD during the twentieth century: an integrated view. Best Pract Res Clin Gastroenterol. 2004;18:463-479. [PMID: 15157821 DOI: 10.1016/j.bpg.2003.12.002] [Cited by in Crossref: 113] [Cited by in F6Publishing: 101] [Article Influence: 6.3] [Reference Citation Analysis]
220 Ho GT, Mowat C, Goddard CJ, Fennell JM, Shah NB, Prescott RJ, Satsangi J. Predicting the outcome of severe ulcerative colitis: development of a novel risk score to aid early selection of patients for second-line medical therapy or surgery. Aliment Pharmacol Ther. 2004;19:1079-1087. [PMID: 15142197 DOI: 10.1111/j.1365-2036.2004.01945.x] [Cited by in Crossref: 183] [Cited by in F6Publishing: 165] [Article Influence: 10.2] [Reference Citation Analysis]
221 Bebb JR, Scott BB. How effective are the usual treatments for ulcerative colitis?: SYSTEMATIC REVIEW: DRUG EFFECTIVENESS IN ULCERATIVE COLITIS. Alimentary Pharmacology & Therapeutics 2004;20:143-9. [DOI: 10.1111/j.1365-2036.2004.02018.x] [Cited by in Crossref: 46] [Cited by in F6Publishing: 38] [Article Influence: 2.6] [Reference Citation Analysis]
222 Arts J, D'Haens G, Zeegers M, Van Assche G, Hiele M, D'Hoore A, Penninckx F, Vermeire S, Rutgeerts P. Long-term outcome of treatment with intravenous cyclosporin in patients with severe ulcerative colitis. Inflamm Bowel Dis. 2004;10:73-78. [PMID: 15168804 DOI: 10.1097/00054725-200403000-00002] [Cited by in Crossref: 173] [Cited by in F6Publishing: 149] [Article Influence: 9.6] [Reference Citation Analysis]
223 Chang JC, Cohen RD. Medical management of severe ulcerative colitis. Gastroenterology Clinics of North America 2004;33:235-50. [DOI: 10.1016/j.gtc.2004.02.005] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
224 Daperno M, Sostegni R, Scaglione N, Ercole E, Rigazio C, Rocca R, Pera A. Outcome of a conservative approach in severe ulcerative colitis. Dig Liver Dis. 2004;36:21-28. [PMID: 14971812 DOI: 10.1016/j.dld.2003.04.001] [Cited by in Crossref: 64] [Cited by in F6Publishing: 56] [Article Influence: 3.6] [Reference Citation Analysis]
225 Carbonnel F. Tube digestif et pancréas. Gastroentérologie Clinique et Biologique 2004;28:215-7. [DOI: 10.1016/s0399-8320(04)94885-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
226 Card T, Hubbard R, Logan RF. Mortality in inflammatory bowel disease: a population-based cohort study. Gastroenterology. 2003;125:1583-1590. [PMID: 14724808 DOI: 10.1053/j.gastro.2003.09.029] [Cited by in Crossref: 103] [Cited by in F6Publishing: 100] [Article Influence: 5.7] [Reference Citation Analysis]
227 Winther KV, Jess T, Langholz E, Munkholm P, Binder V. Survival and cause-specific mortality in ulcerative colitis: follow-up of a population-based cohort in Copenhagen County. Gastroenterology. 2003;125:1576-1582. [PMID: 14724807 DOI: 10.1053/j.gastro.2003.09.036] [Cited by in Crossref: 136] [Cited by in F6Publishing: 131] [Article Influence: 7.6] [Reference Citation Analysis]
228 Ghanchi FD, Rembacken BJ. Inflammatory bowel disease and the eye. Surv Ophthalmol. 2003;48:663-676. [PMID: 14609712 DOI: 10.1016/j.survophthal.2003.08.004] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 2.7] [Reference Citation Analysis]
229 Fedorak R. Conservative approach to severe ulcerative colitis. Digestive and Liver Disease 2004;36:4-6. [DOI: 10.1016/j.dld.2003.10.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
230 Guidat A, Fleyfel M, Vallet B, Desreumaux P, Levron JC, Gambiez L, Colombel JF, Scherpereel P. Inflammation increases sufentanil requirements during surgery for inflammatory bowel diseases: . European Journal of Anaesthesiology 2003;20:957-62. [DOI: 10.1097/00003643-200312000-00004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
231 Van Assche G, D'Haens G, Noman M, Vermeire S, Hiele M, Asnong K, Arts J, D'Hoore A, Penninckx F, Rutgeerts P. Randomized, double-blind comparison of 4 mg/kg vs 2 mg/kg intravenous cyclosporine in severe ulcerative colitis. Gastroenterology. 2003;125:1025-1031. [PMID: 14517785 DOI: 10.1016/s0016-5085(03)01214-9] [Cited by in Crossref: 286] [Cited by in F6Publishing: 249] [Article Influence: 15.1] [Reference Citation Analysis]
232 Rizzello F, Gionchetti P, Venturi A, Campieri M. Review article: medical treatment of severe ulcerative colitis. Aliment Pharmacol Ther 2003;17 Suppl 2:7-10. [PMID: 12786606 DOI: 10.1046/j.1365-2036.17.s2.18.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
233 Campbell S, Ghosh S. Combination immunomodulatory therapy with cyclosporine and azathioprine in corticosteroid-resistant severe ulcerative colitis: the Edinburgh experience of outcome. Digestive and Liver Disease 2003;35:546-51. [DOI: 10.1016/s1590-8658(03)00270-6] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.2] [Reference Citation Analysis]
234 Haber HP, Busch A, Ziebach R, Dette S, Ruck P, Stern M. Ultrasonographic findings correspond to clinical, endoscopic, and histologic findings in inflammatory bowel disease and other enterocolitides. J Ultrasound Med 2002;21:375-82. [PMID: 11934094 DOI: 10.7863/jum.2002.21.4.375] [Cited by in Crossref: 57] [Cited by in F6Publishing: 51] [Article Influence: 3.0] [Reference Citation Analysis]
235 Page MJ, Poritz LS, Kunselman SJ, Koltun WA. Factors affecting surgical risk in elderly patients with inflammatory bowel disease. J Gastrointest Surg. 2002;6:606-613. [PMID: 12127128 DOI: 10.1016/S1091-255X(01)00060-9] [Cited by in Crossref: 48] [Cited by in F6Publishing: 43] [Article Influence: 2.5] [Reference Citation Analysis]
236 Domènech E, Garcia-Planella E, Bernal I, Rosinach M, Cabré E, Fluvià L, Boix J, Gassull MA. Azathioprine without oral ciclosporin in the long-term maintenance of remission induced by intravenous ciclosporin in severe, steroid-refractory ulcerative colitis. Aliment Pharmacol Ther. 2002;16:2061-2065. [PMID: 12452938 DOI: 10.1046/j.1365-2036.2002.01385.x] [Cited by in Crossref: 65] [Cited by in F6Publishing: 56] [Article Influence: 3.4] [Reference Citation Analysis]
237 Dunckley P, Jewell D. Management of acute severe colitis. Best Practice & Research Clinical Gastroenterology 2003;17:89-103. [DOI: 10.1053/bega.2002.0343] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
238 Rizzello F, Gionchetti P, Venturi A, Amadini C, Romagnoli R, Campieri M. Review article: monitoring activity in ulcerative colitis. Aliment Pharmacol Ther 2002;16 Suppl 4:3-6. [PMID: 12047252 DOI: 10.1046/j.1365-2036.16.s4.1.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
239 Fujiya M, Saitoh Y, Nomura M, Maemoto A, Fujiya K, Watari J, Ashida T, Ayabe T, Obara T, Kohgo Y. Minute findings by magnifying colonoscopy are useful for the evaluation of ulcerative colitis. Gastrointest Endosc. 2002;56:535-542. [PMID: 12297770 DOI: 10.1016/s0016-5107(02)70439-2] [Cited by in Crossref: 46] [Cited by in F6Publishing: 30] [Article Influence: 2.3] [Reference Citation Analysis]
240 Ardizzone S, Bianchi Porro G. Comparative tolerability of therapies for ulcerative colitis. Drug Saf. 2002;25:561-582. [PMID: 12113642 DOI: 10.2165/00002018-200225080-00003] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.2] [Reference Citation Analysis]
241 Pikarsky A, Zmora O, Wexner SD. Immunosuppressants and operation in ulcerative colitis1 1No competing interests declared.Invited lecture at the American College of Surgeons 86th Annual Clinical Congress, Chicago, IL, October 2000. Journal of the American College of Surgeons 2002;195:251-60. [DOI: 10.1016/s1072-7515(02)01227-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
242 Daperno M, Sostegni R, Rocca R, Rigazio C, Scaglione N, Castellino F, Ercole E, Pera A. Medical treatment of severe ulcerative colitis: REVIEW: MEDICAL TREATMENT OF SEVERE ULCERATIVE COLITIS. Alimentary Pharmacology & Therapeutics 2002;16:7-12. [DOI: 10.1046/j.1365-2036.16.s4.2.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 1.5] [Reference Citation Analysis]
243 Katz S. Update in medical therapy of ulcerative colitis: a practical approach. J Clin Gastroenterol. 2002;34:397-407. [PMID: 11907350 DOI: 10.1097/00004836-200204000-00004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
244 Moum B, Ekbom A. Epidemiology of inflammatory bowel disease — methodological considerations. Digestive and Liver Disease 2002;34:364-9. [DOI: 10.1016/s1590-8658(02)80131-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
245 Hookman P, Barkin JS. What should be the standard care for cancer surveillance, diagnosis of dysplasia, and the decision for colectomy in chronic inflammatory bowel disease? Am J Gastroenterol 2002;97:1249-55. [PMID: 12046589 DOI: 10.1111/j.1572-0241.2002.05678.x] [Reference Citation Analysis]
246 Gurudu S, Fiocchi C, Katz JA. Inflammatory bowel disease. Best Practice & Research Clinical Gastroenterology 2002;16:77-90. [DOI: 10.1053/bega.2001.0267] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
247 Viscido A, Bagnardi V, Sturniolo G, Annese V, Frieri G, D'arienzo A, Papi C, Riegler G, Corrao G, Caprilli R. Survival and causes of death in Italian patients with ulcerative colitis A GISC nation-wide study. Digestive and Liver Disease 2001;33:686-92. [DOI: 10.1016/s1590-8658(01)80046-3] [Cited by in Crossref: 36] [Cited by in F6Publishing: 41] [Article Influence: 1.7] [Reference Citation Analysis]
248 Eaden J, Abrams K, McKay H, Denley H, Mayberry J. Inter-observer variation between general and specialist gastrointestinal pathologists when grading dysplasia in ulcerative colitis. J Pathol. 2001;194:152-157. [PMID: 11400142 DOI: 10.1002/path.876] [Cited by in Crossref: 164] [Cited by in F6Publishing: 135] [Article Influence: 7.8] [Reference Citation Analysis]
249 D'Haens G, Lemmens L, Geboes K, Vandeputte L, Van Acker F, Mortelmans L, Peeters M, Vermeire S, Penninckx F, Nevens F. Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis. Gastroenterology. 2001;120:1323-1329. [PMID: 11313301 DOI: 10.1053/gast.2001.23983] [Cited by in Crossref: 280] [Cited by in F6Publishing: 258] [Article Influence: 13.3] [Reference Citation Analysis]
250 Blomberg B, Järnerot G. Clinical evaluation and management of acute severe colitis. Inflamm Bowel Dis. 2000;6:214-227. [PMID: 10961594 DOI: 10.1097/00054725-200008000-00008] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.0] [Reference Citation Analysis]
251 Su C, Lichtenstein GR, Lichtenstein GR. Diagnosis of Crohn's Disease: A Wolf in Sheep's Clothing? American Journal of Gastroenterology 2000;95:3345-50. [DOI: 10.1111/j.1572-0241.2000.03343.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
252 Eaden JA, Mayberry JF. Colorectal cancer complicating ulcerative colitis: a review. Am J Gastroenterol. 2000;95:2710-2719. [PMID: 11051339 DOI: 10.1111/j.1572-0241.2000.02297.x] [Cited by in Crossref: 79] [Cited by in F6Publishing: 73] [Article Influence: 3.6] [Reference Citation Analysis]
253 Gelbmann CM. Prediction of treatment refractoriness in ulcerative colitis and Crohn's disease--do we have reliable markers? Inflamm Bowel Dis 2000;6:123-31. [PMID: 10833072 DOI: 10.1097/00054725-200005000-00009] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
254 Moum B. Medical treatment: does it influence the natural course of inflammatory bowel disease? European Journal of Internal Medicine 2000;11:197-203. [DOI: 10.1016/s0953-6205(00)00091-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
255 Rowe FA, Walker JH, Karp LC, Vasiliauskas EA, Plevy SE, Targan SR. Factors predictive of response to cyclosporin treatment for severe, steroid-resistant ulcerative colitis. Am J Gastroenterol 2000;95:2000-8. [PMID: 10950049 DOI: 10.1111/j.1572-0241.2000.02186.x] [Cited by in Crossref: 65] [Cited by in F6Publishing: 58] [Article Influence: 3.0] [Reference Citation Analysis]
256 Caprilli R, Latella G, Vernia P, Frieri G. Multiple organ dysfunction in ulcerative colitis. Am J Gastroenterol. 2000;95:1258-1262. [PMID: 10811337 DOI: 10.1111/j.1572-0241.2000.02019.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 1.4] [Reference Citation Analysis]
257 Carbonnel F, Gargouri D, Lémann M, Beaugerie L, Cattan S, Cosnes J, Gendre JP. Predictive factors of outcome of intensive intravenous treatment for attacks of ulcerative colitis. Aliment Pharmacol Ther. 2000;14:273-279. [PMID: 10735919 DOI: 10.1046/j.1365-2036.2000.00705.x] [Cited by in Crossref: 92] [Cited by in F6Publishing: 81] [Article Influence: 4.2] [Reference Citation Analysis]
258 Moum B, Ekbom A, Vatn MH, Elgjo K. Change in the extent of colonoscopic and histological involvement in ulcerative colitis over time. Am J Gastroenterol. 1999;94:1564-1569. [PMID: 10364026 DOI: 10.1111/j.1572-0241.1999.01145.x] [Cited by in Crossref: 100] [Cited by in F6Publishing: 88] [Article Influence: 4.3] [Reference Citation Analysis]
259 Cohen RD, Brodsky AL, Hanauer SB. A comparison of the quality of life in patients with severe ulcerative colitis after total colectomy versus medical treatment with intravenous cyclosporin. Inflamm Bowel Dis 1999;5:1-10. [PMID: 10028443 DOI: 10.1097/00054725-199902000-00001] [Cited by in Crossref: 52] [Cited by in F6Publishing: 55] [Article Influence: 2.3] [Reference Citation Analysis]
260 Stack WA, Long RG, Hawkey CJ. Short- and long-term outcome of patients treated with cyclosporin for severe acute ulcerative colitis. Aliment Pharmacol Ther. 1998;12:973-978. [PMID: 9798801 DOI: 10.1046/j.1365-2036.1998.00396.x] [Cited by in Crossref: 66] [Cited by in F6Publishing: 60] [Article Influence: 2.9] [Reference Citation Analysis]
261 Hjortswang H, Ström M, Almer S. Health-related quality of life in Swedish patients with ulcerative colitis. Am J Gastroenterol. 1998;93:2203-2211. [PMID: 9820397 DOI: 10.1111/j.1572-0241.1998.00537.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 2.0] [Reference Citation Analysis]
262 Sturniolo GC, Mestriner C, Lecis PE, D'Odorico A, Venturi C, Irato P, Cecchetto A, Tropea A, Longo G, D'Inca R. Altered plasma and mucosal concentrations of trace elements and antioxidants in active ulcerative colitis. Scand J Gastroenterol. 1998;33:644-649. [PMID: 9669638 DOI: 10.1080/00365529850171936] [Cited by in Crossref: 57] [Cited by in F6Publishing: 52] [Article Influence: 2.4] [Reference Citation Analysis]
263 Ekbom A. Risk Factors and Distinguishing Features of Cancer in IBD: . Inflammatory Bowel Diseases 1998;4:235-43. [DOI: 10.1097/00054725-199808000-00007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis]
264 Ardizzone S, Bianchi Porro G. A practical guide to the management of distal ulcerative colitis. Drugs. 1998;55:519-542. [PMID: 9561342 DOI: 10.2165/00003495-199855040-00004] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 1.4] [Reference Citation Analysis]
265 Roy MA. Inflammatory bowel disease. Surg Clin North Am 1997;77:1419-31. [PMID: 9431347 DOI: 10.1016/s0039-6109(05)70625-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
266 Hudson M, Flett G, Sinclair TS, Brunt PW, Templeton A, Mowat NA. Fertility and pregnancy in inflammatory bowel disease. Int J Gynaecol Obstet. 1997;58:229-237. [PMID: 9252260 DOI: 10.1016/s0020-7292(97)00088-x] [Cited by in Crossref: 159] [Cited by in F6Publishing: 148] [Article Influence: 6.4] [Reference Citation Analysis]
267 Selby W. The natural history of ulcerative colitis. Baillieres Clin Gastroenterol. 1997;11:53-64. [PMID: 9192060 DOI: 10.1016/s0950-3528(97)90053-1] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 1.2] [Reference Citation Analysis]
268 Leiper K, London IJ, Rhodes JM. Management of the first presentation of severe acute colitis. Baillieres Clin Gastroenterol. 1997;11:129-151. [PMID: 9192065 DOI: 10.1016/s0950-3528(97)90058-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
269 Ardizzone S, Molteni F, Imbesi V, Bollani S, Porro GB. Azathioprine in Steroid-Resistant and Steroid-Dependent Ulcerative Colitis: . Journal of Clinical Gastroenterology 1997;25:330-3. [DOI: 10.1097/00004836-199707000-00007] [Cited by in Crossref: 78] [Cited by in F6Publishing: 81] [Article Influence: 3.1] [Reference Citation Analysis]
270 Irvine EJ. Quality of life in inflammatory bowel disease and other chronic diseases. Scand J Gastroenterol Suppl 1996;221:26-8. [PMID: 9110394 DOI: 10.3109/00365529609095550] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 0.5] [Reference Citation Analysis]
271 Carbonnel F, Boruchowicz A, Duclos B, Soulé JC, Lerebours E, Lémann M, Belaïche J, Colombel JF, Cosnes J, Gendre JP. Intravenous cyclosporine in attacks of ulcerative colitis: short-term and long-term responses. Dig Dis Sci. 1996;41:2471-2476. [PMID: 9011460 DOI: 10.1007/bf02100145] [Cited by in Crossref: 96] [Cited by in F6Publishing: 81] [Article Influence: 3.8] [Reference Citation Analysis]
272 SKYRING A, ROBERTS R. CHILDHOOD ULCERATIVE COLITIS: AN EPIDEMIOLOGICAL STUDY IN N.S.W. Med J Aust 1965;1:955-60. [PMID: 14333758 DOI: 10.5694/j.1326-5377.1965.tb18420.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.2] [Reference Citation Analysis]
273 BROOKE BN, SAMPSON PA. AN INDICATION FOR SURGERY IN ACUTE ULCERATIVE COLITIS. Lancet 1964;2:1272-3. [PMID: 14219132 DOI: 10.1016/s0140-6736(64)92740-0] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 0.8] [Reference Citation Analysis]
274 Irvine E, Feagan B, Wong C. Does self-administration of a quality of life index for inflammatory bowel disease change the results? Journal of Clinical Epidemiology 1996;49:1177-85. [DOI: 10.1016/0895-4356(96)00136-9] [Cited by in Crossref: 53] [Cited by in F6Publishing: 51] [Article Influence: 2.0] [Reference Citation Analysis]
275 Travis SP, Farrant JM, Ricketts C, Nolan DJ, Mortensen NM, Kettlewell MG, Jewell DP. Predicting outcome in severe ulcerative colitis. Gut 1996;38:905-10. [PMID: 8984031 DOI: 10.1136/gut.38.6.905] [Cited by in Crossref: 488] [Cited by in F6Publishing: 429] [Article Influence: 18.8] [Reference Citation Analysis]
276 Hamada Y, Kobayashi K, Podolsky DK, Brown WR. Increased Cytoplasmic Accumulation of Goblet Cell Glycoproteins in Ulcerative Colitis: . Inflammatory Bowel Diseases 1996;2:97-104. [DOI: 10.1097/00054725-199606000-00005] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
277 Keränen U, Kiviluoto T, Järvinen H, Bäck N, Kivilaakso E, Soinila S. Changes in substance P-immunoreactive innervation of human colon associated with ulcerative colitis. Dig Dis Sci 1995;40:2250-8. [PMID: 7587798 DOI: 10.1007/BF02209015] [Cited by in Crossref: 56] [Cited by in F6Publishing: 53] [Article Influence: 2.1] [Reference Citation Analysis]
278 Andrews JM, Norton I, Dent O, Goulston K. Inflammatory bowel disease: a retrospective review of a specialist‐based cohort. Medical Journal of Australia 1995;163:133-6. [DOI: 10.5694/j.1326-5377.1995.tb127960.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.4] [Reference Citation Analysis]
279 D'incà R, Sturniolo GC, Martines D, Di Leo V, Cecchetto A, Venturi C, Naccarato R. Functional and morphological changes in small bowel of crohn's disease patients: Influence of site of disease. Digest Dis Sci 1995;40:1388-93. [DOI: 10.1007/bf02065556] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 0.4] [Reference Citation Analysis]
280 Kirsner JB. The historical basis of the idiopathic inflammatory bowel diseases. Inflamm Bowel Dis 1995;1:2-26. [DOI: 10.1002/ibd.3780010103] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
281 Kirsner JB. The Historical Basis of the Idiopathic Inflammatory Bowel Diseases: . Inflammatory Bowel Diseases 1995;1:2-26. [DOI: 10.1097/00054725-199503000-00002] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
282 Fleischer DE, Grimm IS, Friedman LS. Inflammatory bowel disease in older patients. Medical Clinics of North America 1994;78:1303-19. [DOI: 10.1016/s0025-7125(16)30102-x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 1.2] [Reference Citation Analysis]
283 Katz J. The course of inflammatory bowel disease. Medical Clinics of North America 1994;78:1275-80. [DOI: 10.1016/s0025-7125(16)30100-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 0.6] [Reference Citation Analysis]
284 Langholz E, Munkholm P, Davidsen M, Binder V. Course of ulcerative colitis: analysis of changes in disease activity over years. Gastroenterology 1994;107:3-11. [PMID: 8020674 DOI: 10.1016/0016-5085(94)90054-x] [Cited by in Crossref: 452] [Cited by in F6Publishing: 412] [Article Influence: 16.1] [Reference Citation Analysis]
285 Rosenthal RA. Small-Bowel Disorders and Abdominal Wall Hernia in the Elderly Patient. Surgical Clinics of North America 1994;74:261-91. [DOI: 10.1016/s0039-6109(16)46283-3] [Cited by in Crossref: 31] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
286 Andrews J, Goulston K. Inflammatory bowel disease — its history, current status and outlook. Medical Journal of Australia 1994;160:219-23. [DOI: 10.5694/j.1326-5377.1994.tb126608.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
287 Farmer RG, Easley KA, Rankin GB. Clinical patterns, natural history, and progression of ulcerative colitis. A long-term follow-up of 1116 patients. Dig Dis Sci 1993;38:1137-46. [PMID: 8508710 DOI: 10.1007/BF01295733] [Cited by in Crossref: 266] [Cited by in F6Publishing: 234] [Article Influence: 9.2] [Reference Citation Analysis]
288 Tysk C, Järnerot G. Ulcerative proctocolitis in Orebro, Sweden. A retrospective epidemiologic study, 1963-1987. Scand J Gastroenterol. 1992;27:945-950. [PMID: 1455192 DOI: 10.3109/00365529209000168] [Cited by in Crossref: 74] [Cited by in F6Publishing: 121] [Article Influence: 2.6] [Reference Citation Analysis]
289 Ekbom A, Helmick CG, Zack M, Holmberg L, Adami HO. Survival and causes of death in patients with inflammatory bowel disease: a population-based study. Gastroenterology. 1992;103:954-960. [PMID: 1499945 DOI: 10.1016/0016-5085(92)90029-x] [Cited by in Crossref: 184] [Cited by in F6Publishing: 168] [Article Influence: 6.1] [Reference Citation Analysis]
290 Tysk C, Järnerot G. Has smoking changed the epidemiology of ulcerative colitis? Scand J Gastroenterol. 1992;27:508-512. [PMID: 1631497 DOI: 10.3109/00365529209000113] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 0.7] [Reference Citation Analysis]
291 Porschen R, Robin U, Schumacher A, Schauseil S, Borchard F, Hengels KJ, Strohmeyer G. DNA aneuploidy in Crohn's disease and ulcerative colitis: results of a comparative flow cytometric study. Gut 1992;33:663-7. [PMID: 1612484 DOI: 10.1136/gut.33.5.663] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 1.0] [Reference Citation Analysis]
292 Froines EJ, Palmer DL. Surgical therapy for rectovaginal fistulas in ulcerative colitis. Diseases of the Colon & Rectum 1991;34:925-30. [DOI: 10.1007/bf02049710] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
293 Magni G, Bernasconi G, Mauro P, D'Odorico A, Sturniolo GC, Canton G, Martin A. Psychiatric diagnoses in ulcerative colitis. A controlled study. Br J Psychiatry. 1991;158:413-415. [PMID: 2036541 DOI: 10.1192/bjp.158.3.413] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 0.7] [Reference Citation Analysis]
294 Hiwatashi N, Yamazaki H, Kimura M, Morimoto T, Watanabe H, Toyota T. Clinical course and long-term prognosis of Japanese patients with ulcerative colitis. Gastroenterol Jpn 1991;26:312-8. [DOI: 10.1007/bf02781919] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
295 Froese DP, Haggitt RC, Friend WG. Ulcerative colitis in the autotransplanted neovagina. Gastroenterology 1991;100:1749-52. [DOI: 10.1016/0016-5085(91)90679-f] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 0.9] [Reference Citation Analysis]
296 Robert JH, Sachar DB, Aufses AH, Greenstein AJ. Management of severe hemorrhage in ulcerative colitis. The American Journal of Surgery 1990;159:550-5. [DOI: 10.1016/s0002-9610(06)80064-4] [Cited by in Crossref: 69] [Cited by in F6Publishing: 53] [Article Influence: 2.2] [Reference Citation Analysis]
297 Grimm IS, Friedman LS. Inflammatory Bowel Disease in the Elderly. Gastroenterology Clinics of North America 1990;19:361-89. [DOI: 10.1016/s0889-8553(21)00501-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.4] [Reference Citation Analysis]
298 Halstensen TS, Mollnes TE, Garred P, Fausa O, Brandtzaeg P. Epithelial Deposition of Immunoglobulin G1 and Activated Complement (C3b and Terminal Complement Complex) in Ulcerative Colitis. Gastroenterology 1990;98:1264-71. [DOI: 10.1016/0016-5085(90)90343-y] [Cited by in Crossref: 102] [Cited by in F6Publishing: 94] [Article Influence: 3.2] [Reference Citation Analysis]
299 Leijonmarck CE, Persson PG, Hellers G. Factors affecting colectomy rate in ulcerative colitis: an epidemiologic study. Gut 1990;31:329-33. [PMID: 2323599 DOI: 10.1136/gut.31.3.329] [Cited by in Crossref: 147] [Cited by in F6Publishing: 127] [Article Influence: 4.6] [Reference Citation Analysis]
300 Qureshi H, Zuberi SJ, Banatwala N, Anwar A, Shamsi Z, Khan MN. Ulcerative colitis in Karachi. J Gastroenterol Hepatol 1989;4:313-6. [DOI: 10.1111/j.1440-1746.1989.tb00841.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
301 Jewell D. Corticosteroids for the Management of Ulcerative Colitis and Crohn’s Disease. Gastroenterology Clinics of North America 1989;18:21-34. [DOI: 10.1016/s0889-8553(21)00422-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 0.6] [Reference Citation Analysis]
302 Danovitch SH. Fulminant Colitis and Toxic Megacolon. Gastroenterology Clinics of North America 1989;18:73-82. [DOI: 10.1016/s0889-8553(21)00427-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
303 Truelove SC. Medical management of ulcerative colitis and indications for colectomy. World J Surg 1988;12:142-7. [PMID: 2899365 DOI: 10.1007/BF01658044] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 0.6] [Reference Citation Analysis]
304 Riley SA, Mani V, Goodman MJ, Herd ME, Dutt S, Turnberg LA. Comparison of delayed-release 5-aminosalicylic acid (mesalazine) and sulfasalazine as maintenance treatment for patients with ulcerative colitis. Gastroenterology. 1988;94:1383-1389. [PMID: 2896139 DOI: 10.1016/0016-5085(88)90677-4] [Cited by in Crossref: 131] [Cited by in F6Publishing: 128] [Article Influence: 3.9] [Reference Citation Analysis]
305 Benfield GF, Montgomery RD, Asquith P. Ulcerative colitis in Asian immigrants. Postgrad Med J 1987;63:629-35. [PMID: 3422862 DOI: 10.1136/pgmj.63.742.629] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.2] [Reference Citation Analysis]
306 Gyde SN, Prior P, Allan RN, Stevens A, Jewell DP, Truelove SC, Lofberg R, Brostrom O, Hellers G. Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres. Gut 1988;29:206-17. [PMID: 3345932 DOI: 10.1136/gut.29.2.206] [Cited by in Crossref: 334] [Cited by in F6Publishing: 306] [Article Influence: 9.8] [Reference Citation Analysis]
307 Broström O, Monsén U, Nordenwall B, Sörstad J, Hellers G. Prognosis and mortality of ulcerative colitis in Stockholm County, 1955-1979. Scand J Gastroenterol 1987;22:907-13. [PMID: 3685878 DOI: 10.3109/00365528708991934] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 0.8] [Reference Citation Analysis]
308 Harms BA, Hamilton JW, Starling JR. Management of chronic ulcerative colitis and rectovaginal fistula by simultaneous ileal pouch construction and fistula closure: Report of a case. Diseases of the Colon & Rectum 1987;30:611-4. [DOI: 10.1007/bf02554808] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
309 Jones HW, Grogono J, Hoare AM. Acute colitis in a district general hospital. Br Med J (Clin Res Ed). 1987;294:683-684. [PMID: 3105688 DOI: 10.1136/bmj.294.6573.683] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.3] [Reference Citation Analysis]
310 Vickers CR, Gallagher ND, Glenn DC, Morgan BP, Goulston SJ. A reappraisal of the management of severe colitis in its fulminant phase. J Gastroenterol Hepatol 1987;2:217-23. [DOI: 10.1111/j.1440-1746.1987.tb00157.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
311 Fischbach W, Becker W, Mössner J, Koch W, Reiners C. Faecal alpha-1-antitrypsin and excretion of 111indium granulocytes in assessment of disease activity in chronic inflammatory bowel diseases. Gut 1987;28:386-93. [PMID: 3495470 DOI: 10.1136/gut.28.4.386] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 1.2] [Reference Citation Analysis]
312 Søndergaard JO, Svendsen LB, Hegnhøj JO, Witt IN. Mandibular osteomas in ulcerative colitis. Scand J Gastroenterol 1986;21:1089-90. [PMID: 3810009 DOI: 10.3109/00365528608996426] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.3] [Reference Citation Analysis]
313 Farmer RG. Nonspecific Ulcerative Proctitis. Gastroenterology Clinics of North America 1987;16:157-74. [DOI: 10.1016/s0889-8553(21)00487-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
314 Nordenvall B, Broström O, Berglund M, Monsen U, Nordenström J, Sörstad J, Hellers G. Incidence of ulcerative colitis in Stockholm County 1955-1979. Scand J Gastroenterol 1985;20:783-90. [PMID: 4048831 DOI: 10.3109/00365528509088823] [Cited by in Crossref: 65] [Cited by in F6Publishing: 114] [Article Influence: 1.8] [Reference Citation Analysis]
315 Järnerot G, Rolny P, Sandberg-Gertzén H. Intensive intravenous treatment of ulcerative colitis. Gastroenterology 1985;89:1005-13. [PMID: 3930339 DOI: 10.1016/0016-5085(85)90201-x] [Cited by in Crossref: 264] [Cited by in F6Publishing: 232] [Article Influence: 7.1] [Reference Citation Analysis]
316 Slater G, Greenstein AJ, Gelernt I, Kreel I, Bauer J, Aufses AH. Distribution of colorectal cancer in patients with and without ulcerative colitis. The American Journal of Surgery 1985;149:780-2. [DOI: 10.1016/s0002-9610(85)80185-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
317 Sinclair TS, Brunt PW, Mowat NA. Nonspecific proctocolitis in northeastern Scotland: a community study. Gastroenterology. 1983;85:1-11. [PMID: 6852444 DOI: 10.1016/s0016-5085(83)80221-2] [Cited by in Crossref: 139] [Cited by in F6Publishing: 106] [Article Influence: 3.6] [Reference Citation Analysis]
318 Gilat T. Incidence of Inflammatory Bowel Disease: Going Up or Down? Gastroenterology 1983;85:196-7. [DOI: 10.1016/s0016-5085(83)80251-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
319 Goldman H, Antonioli DA. Mucosal biopsy of the rectum, colon, and distal ileum. Hum Pathol 1982;13:981-1012. [PMID: 6759364 DOI: 10.1016/s0046-8177(82)80092-0] [Cited by in Crossref: 64] [Cited by in F6Publishing: 54] [Article Influence: 1.6] [Reference Citation Analysis]
320 Stein DT, Gray GM, Gregory PB, Anderson M, Goodwin DA, Mcdougall LR. Location and Activity of Ulcerative and Crohn's Colitis by Indium 111 Leukocyte Scan. Gastroenterology 1983;84:388-93. [DOI: 10.1016/s0016-5085(83)80138-3] [Cited by in Crossref: 51] [Cited by in F6Publishing: 40] [Article Influence: 1.3] [Reference Citation Analysis]
321 Powell-Tuck J, Day DW, Buckell NA, Wadsworth J, Lennard-Jones JE. Correlations between defined sigmoidoscopic appearances and other measures of disease activity in ulcerative colitis. Dig Dis Sci. 1982;27:533-537. [PMID: 6979471 DOI: 10.1007/bf01296733] [Cited by in Crossref: 135] [Cited by in F6Publishing: 128] [Article Influence: 3.4] [Reference Citation Analysis]
322 Gyde S, Prior P, Dew M, Saunders V, Waterhouse J, Allan R. Mortality in Ulcerative Colitis. Gastroenterology 1982;83:36-43. [DOI: 10.1016/s0016-5085(82)80281-3] [Cited by in Crossref: 84] [Cited by in F6Publishing: 51] [Article Influence: 2.1] [Reference Citation Analysis]
323 Rognum TO, Elgjo K, Fausa O, Brandtzaeg P. Immunohistochemical evaluation of carcinoembryonic antigen, secretory component, and epithelial IgA in ulcerative colitis with dysplasia. Gut 1982;23:123-33. [PMID: 7040173 DOI: 10.1136/gut.23.2.123] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 0.8] [Reference Citation Analysis]
324 Albrechtsen D, Bergan A, Nygaard K, Gjone E, Flatmark A. Urgent surgery for ulcerative colitis: Early colectomy in 132 patients. World J Surg 1981;5:607-14. [DOI: 10.1007/bf01655016] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 0.7] [Reference Citation Analysis]
325 Chapman RW, Arborgh BA, Rhodes JM, Summerfield JA, Dick R, Scheuer PJ, Sherlock S. Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. Gut. 1980;21:870-877. [PMID: 7439807 DOI: 10.1136/gut.21.10870] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
326 Lee EC, Truelove SC. Proctocolectomy for ulcerative colitis. World J Surg 1980;4:195-201. [PMID: 7405257 DOI: 10.1007/BF02393575] [Cited by in Crossref: 37] [Cited by in F6Publishing: 29] [Article Influence: 0.9] [Reference Citation Analysis]
327 Chapman RW, Arborgh BA, Rhodes JM, Summerfield JA, Dick R, Scheuer PJ, Sherlock S. Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. Gut 1980;21:870-7. [PMID: 7439807 DOI: 10.1136/gut.21.10.870] [Cited by in Crossref: 520] [Cited by in F6Publishing: 487] [Article Influence: 12.4] [Reference Citation Analysis]
328 Buckell N, Williams G, Bartram C, Lennard-jones J. Depth of ulceration in acute colitis. Gastroenterology 1980;79:19-25. [DOI: 10.1016/0016-5085(80)90069-4] [Cited by in Crossref: 57] [Cited by in F6Publishing: 45] [Article Influence: 1.4] [Reference Citation Analysis]
329 Willoughby CP, Piris J, Truelove SC. Campylobacter colitis. J Clin Pathol 1979;32:986-9. [PMID: 521500 DOI: 10.1136/jcp.32.10.986] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
330 Robison WW, Bentlif PS, Kelsey JR. Observations on 261 consecutive patients with inflammatory bowel disease seen in the southwest United States. Digest Dis Sci 1980;25:198-204. [DOI: 10.1007/bf01308139] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.3] [Reference Citation Analysis]
331 Blaser MJ, Parsons RB, Wang WL. Acute colitis caused by Campylobacter fetus ss. jejuni. Gastroenterology 1980;78:448-53. [DOI: 10.1016/0016-5085(80)90855-0] [Cited by in Crossref: 94] [Cited by in F6Publishing: 37] [Article Influence: 2.2] [Reference Citation Analysis]
332 Robertson RH, Mcdowell HA, Jander H, Groarke J. Toxic megacolon due to ischemic enterocolitis associated with retroperitoneal fibrosis. Gastroenterology 1980;78:585-91. [DOI: 10.1016/0016-5085(80)90876-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
333 Storgaard L, Bischoff N, Henriksen FW, Fischerman K, Jarnum S. Survival rate in Crohn's disease and ulcerative colitis. Scand J Gastroenterol 1979;14:225-30. [PMID: 432545 DOI: 10.3109/00365527909179874] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 0.6] [Reference Citation Analysis]
334 Dronfield MW, Langman MJ. Comparative trial of sulphasalazine and oral sodium cromoglycate in the maintenance of remission in ulcerative colitis. Gut 1978;19:1136-9. [PMID: 33875 DOI: 10.1136/gut.19.12.1136] [Cited by in Crossref: 37] [Cited by in F6Publishing: 29] [Article Influence: 0.8] [Reference Citation Analysis]
335 Ritchie JK, Powell-Tuck J, Lennard-Jones JE. Clinical outcome of the first ten years of ulcerative colitis and proctitis. Lancet. 1978;1:1140-1143. [PMID: 77426 DOI: 10.1016/S0140-6736(78)90312-4] [Cited by in Crossref: 86] [Cited by in F6Publishing: 72] [Article Influence: 2.0] [Reference Citation Analysis]
336 Werlin SL, Grand RJ. Severe Colitis in Children and Adolescents: Diagnosis, Course, and Treatment. Gastroenterology 1977;73:828-32. [DOI: 10.1016/s0016-5085(19)31792-5] [Cited by in Crossref: 68] [Cited by in F6Publishing: 47] [Article Influence: 1.5] [Reference Citation Analysis]
337 Schjonsby H, Heimann P, Kremer D, Nordgård K, Raugstad TS, Ringheim F, Stray O. Intensive treatment in severe acute attacks of ulcerative colitis. Acta Med Scand Suppl 1977;603:43-6. [PMID: 266836 DOI: 10.1111/j.0954-6820.1977.tb19359.x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
338 Mallas E, Terry JM, Asquith P, Cooke WT. Serum lysozyme in inflammatory bowel and coeliac disease. J Clin Pathol 1976;29:598-600. [PMID: 977770 DOI: 10.1136/jcp.29.7.598] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 0.3] [Reference Citation Analysis]
339 Truelove SC, Pena AS. Course and prognosis of Crohn's disease. Gut 1976;17:192-201. [PMID: 1269986 DOI: 10.1136/gut.17.3.192] [Cited by in Crossref: 133] [Cited by in F6Publishing: 112] [Article Influence: 2.9] [Reference Citation Analysis]
340 Gilat T, Lilos P, Zemishlany Z, Ribak J, Benaroya Y. Ulcerative Colitis in the Jewish Population of Tel-Aviv Yafo III. Clinical Course. Gastroenterology 1976;70:14-9. [DOI: 10.1016/s0016-5085(76)80396-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
341 Toghill PJ, Benton KP, Smith PG. Chronic liver disease associated with childhood ulcerative colitis. Postgrad Med J 1974;50:9-15. [PMID: 4464504 DOI: 10.1136/pgmj.50.579.9] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 0.5] [Reference Citation Analysis]
342 Lennard-Jones JE, Ritchie JK, Hilder W, Spicer CC. Assessment of severity in colitis: a preliminary study. Gut 1975;16:579-84. [PMID: 1183857 DOI: 10.1136/gut.16.8.579] [Cited by in Crossref: 143] [Cited by in F6Publishing: 123] [Article Influence: 3.0] [Reference Citation Analysis]
343 Jarnum S, Jensen KB. Fecal Radioiodide Excretion Following Intravenous Injection of 131I-Albumin and 125I-Immunoglobulin G in Chronic Inflammatory Bowel Disease. Gastroenterology 1975;68:1433-44. [DOI: 10.1016/s0016-5085(75)80129-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 0.3] [Reference Citation Analysis]
344 Mitchell ABS, Morton Gill A, Orchard RT, Parkins RA. Carcinoembryonic antigen in patients suffering from ulcerative proctocolitis. Digest Dis Sci 1975;20:407-17. [DOI: 10.1007/bf01070784] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
345 Gall DG, Hamilton JR. Chronic Diarrhea in Childhood: A New Look at an Old Problem. Pediatric Clinics of North America 1974;21:1001-17. [DOI: 10.1016/s0031-3955(16)33071-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
346 Truelove SC, Jewell DP. Intensive intravenous regimen for severe attacks of ulcerative colitis. Lancet. 1974;1:1067-1070. [PMID: 4135487 DOI: 10.1016/s0140-6736(74)90552-2] [Cited by in Crossref: 364] [Cited by in F6Publishing: 329] [Article Influence: 7.6] [Reference Citation Analysis]
347 Lennard-Jones JE, Misiewicz JJ, Parrish JA, Ritchie JK, Swarbrick ET, Williams CB. Prospective study of outpatients with extensive colitis. Lancet 1974;1:1065-7. [PMID: 4135244 DOI: 10.1016/s0140-6736(74)90551-0] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 0.7] [Reference Citation Analysis]
348 Sachar DB, Janowitz HD. Inflammatory bowel disease. Disease-a-Month 1974;20:1-44. [DOI: 10.1016/s0011-5029(74)80001-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
349 De Dombal FT, Burton IL, Clamp SE, Goligher JC. Short-term course and prognosis of Crohn's disease. Gut 1974;15:435-43. [PMID: 4854277 DOI: 10.1136/gut.15.6.435] [Cited by in Crossref: 120] [Cited by in F6Publishing: 112] [Article Influence: 2.5] [Reference Citation Analysis]
350 Gilat T, Ribak J, Benaroya Y, Zemishlany Z, Weissman I. Ulcerative Colitis in the Jewish Population of Tel-Aviv Jafo. Gastroenterology 1974;66:335-42. [DOI: 10.1016/s0016-5085(74)80131-9] [Cited by in Crossref: 65] [Cited by in F6Publishing: 95] [Article Influence: 1.4] [Reference Citation Analysis]
351 Goel KM, Shanks RA. Long-term prognosis of children with ulcerative colitis. Arch Dis Child 1973;48:337-42. [PMID: 4703063 DOI: 10.1136/adc.48.5.337] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
352 Scherl ND, Scherl BA. Adjunctive use of a steroid rectal foam in the treatment of ulcerative colitis. Dis Colon Rectum 1973;16:149-51. [PMID: 4702814 DOI: 10.1007/BF02589932] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.1] [Reference Citation Analysis]
353 Sedlack RE, Nobrega FT, Kurland LT, Sauer WG. Inflammatory Colon Disease in Rochester, Minnesota, 1935–1964. Gastroenterology 1972;62:935-41. [DOI: 10.1016/s0016-5085(72)80110-0] [Cited by in Crossref: 65] [Cited by in F6Publishing: 91] [Article Influence: 1.3] [Reference Citation Analysis]
354 Farmer RG, Brown CH. Emerging concepts of proctosigmoiditis. Diseases of the Colon & Rectum 1972;15:142-6. [DOI: 10.1007/bf02587263] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 0.3] [Reference Citation Analysis]
355 Fung WP, Monteiro EH, Murugasu JJ, Ng KC, Kho KM, Lee SK. Non-specific ulcerative colitis in Chinese and Indians in Singapore. Med J Aust 1971;2:361-5. [PMID: 5092891 DOI: 10.5694/j.1326-5377.1971.tb50597.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 60] [Article Influence: 0.1] [Reference Citation Analysis]
356 Graham NG, De Dombal FT, Goligher JC. Reliability of physical signs in patients with severe attacks of ulcerative colitis. Br Med J 1971;2:746-8. [PMID: 5090763 DOI: 10.1136/bmj.2.5764.746] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 0.4] [Reference Citation Analysis]
357 Kronman BS. Ulcerative colitis, autoimmune epiphenomena, and colonic cancer. Cancer 1971;28:82-8. [DOI: 10.1002/1097-0142(197107)28:1<82::aid-cncr2820280116>3.0.co;2-d] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.2] [Reference Citation Analysis]
358 Goligher JC, Hoffman DC, de Dombal FT. Surgical treatment of severe attacks of ulcerative colitis, with special reference to the advantages of early operation. Br Med J 1970;4:703-6. [PMID: 5491253 DOI: 10.1136/bmj.4.5737.703] [Cited by in Crossref: 92] [Cited by in F6Publishing: 77] [Article Influence: 1.8] [Reference Citation Analysis]
359 Jalan K, Prescott R, Sircus W, Card W, Mcmanus J, Falconer C, Small W, Smith A, Bruce J. An Experience of Ulcerative Colitis. Gastroenterology 1970;59:598-609. [DOI: 10.1016/s0016-5085(19)33714-x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 0.4] [Reference Citation Analysis]
360 Jalan K, Prescott R, Sircus W, Card W, Mcmanus J, Falconer C, Small W, Smith A, Bruce J. An Experience of Ulcerative Colitis. Gastroenterology 1970;59:589-97. [DOI: 10.1016/s0016-5085(19)33713-8] [Cited by in Crossref: 30] [Cited by in F6Publishing: 16] [Article Influence: 0.6] [Reference Citation Analysis]
361 Nugent FW, Veidenheimer MC, Zuberi S, Garabedian MM, Parikh NK. Clinical course of ulcerative proctosigmoiditis. Digest Dis Sci 1970;15:321-6. [DOI: 10.1007/bf02239286] [Cited by in Crossref: 30] [Cited by in F6Publishing: 18] [Article Influence: 0.6] [Reference Citation Analysis]
362 Aktan H, Paykoç Z, Ertan A. Ulcerative colitis in Turkey: clinical review of sixty cases. Dis Colon Rectum 1970;13:62-5. [PMID: 5414555 DOI: 10.1007/BF02617689] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 0.3] [Reference Citation Analysis]
363 Morowitz DA, Kirsner JB. Mortality in Ulcerative Colitis: 1930 to 1966. Gastroenterology 1969;57:481-90. [DOI: 10.1016/s0016-5085(19)33842-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 0.3] [Reference Citation Analysis]
364 Iversen E, Bonnevie O, Anthonisen P, Riis P. An epidemiological model of ulcerative colitis. Scand J Gastroenterol. 1968;3:593-610. [PMID: 5731259 DOI: 10.3109/00365526809180141] [Cited by in Crossref: 50] [Cited by in F6Publishing: 92] [Article Influence: 0.9] [Reference Citation Analysis]
365 Jalan K, Sircus W, Card W, Falconer C, Bruce J, Crean G, Mcmanus J, Small W, Smith A. An Experience of Ulcerative Colitis. Gastroenterology 1969;57:68-82. [DOI: 10.1016/s0016-5085(19)33962-9] [Cited by in Crossref: 169] [Cited by in F6Publishing: 92] [Article Influence: 3.2] [Reference Citation Analysis]
366 De Dombal FT. Prognostic value of estimating serum proteins in cases of ulcerative colitis in remission. Gut 1969;10:491-6. [PMID: 4182170 DOI: 10.1136/gut.10.6.491] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.1] [Reference Citation Analysis]
367 Burch PR, de Dombal FT, Watkinson G. Aetiology of ulcerative colitis. II. A new hypothesis. Gut 1969;10:277-84. [PMID: 5782311 DOI: 10.1136/gut.10.4.277] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 0.5] [Reference Citation Analysis]
368 De Dombal FT. Ulcerative colitis: definition, historical background, aetiology, diagnosis, naturel history and local complications. Postgrad Med J. 1968;44:684-692. [PMID: 5705372 DOI: 10.1136/pgmj.44.515.684] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 0.4] [Reference Citation Analysis]
369 Wruble LD, Bronstein MW. Toxic dilatation of the colon following barium enema examination during the quiescent stage of chronic ulcerative colitis: Report of a case. Digest Dis Sci 1968;13:918-24. [DOI: 10.1007/bf02237578] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.1] [Reference Citation Analysis]
370 Goligher JC. Surgical treatment of ulcerative colitis. Br Med J 1968;2:671-4. [PMID: 5658414 DOI: 10.1136/bmj.2.5606.671] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
371 Stelzner F. [52. Inflammatory diseases of the large intestine. Unspecific colitis. (Surgical report)]. Langenbecks Arch Chir 1967;319:333-45. [PMID: 4870748 DOI: 10.1007/BF02659283] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
372 De Dombal FT. Prognostic value of the serum proteins during severe attacks of ulcerative colitis. Gut 1968;9:144-9. [PMID: 4172756 DOI: 10.1136/gut.9.2.144] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 0.4] [Reference Citation Analysis]
373 Chuttani HK, Nigam SP, Sama SK, Dhanda PC, Gupta PS. Ulcerative colitis in the tropics. Br Med J 1967;4:204-7. [PMID: 6053989 DOI: 10.1136/bmj.4.5573.204] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 0.3] [Reference Citation Analysis]
374 Feldman F, Cantor D, Soll S, Bachrach W. Psychiatric study of a consecutive series of 34 patients with ulcerative colitis. Br Med J 1967;3:14-7. [PMID: 6028848 DOI: 10.1136/bmj.3.5556.14] [Cited by in Crossref: 71] [Cited by in F6Publishing: 47] [Article Influence: 1.3] [Reference Citation Analysis]
375 Goligher JC, de Dombal FT, Graham NG, Watkinson G. Early surgery in the management of severe ulcerative colitis. Br Med J 1967;3:193-5. [PMID: 6028463 DOI: 10.1136/bmj.3.5559.193] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 0.6] [Reference Citation Analysis]
376 Sparberg M, Knudsen KB. Fulminant ulcerative colitis with a normal rectum. Digest Dis Sci 1967;12:923-33. [DOI: 10.1007/bf02236450] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
377 Farmer RG, Brown CH. Ulcerative colitis confined to the rectum and sigmoid flexure: Report of 124 cases. Diseases of the Colon & Rectum 1967;10:177-82. [DOI: 10.1007/bf02617175] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
378 Watts JM, de Dombal FT, Goligher JC. Early results of surgery for ulcerative colitis. Br J Surg. 1966;53:1005-1014. [PMID: 5927651 DOI: 10.1002/bjs.1800531202] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 0.9] [Reference Citation Analysis]
379 Watts JM, De Dombal FT, Watkinson G, Goligher JC. Long-term prognosis of ulcerative colitis. Br Med J 1966;1:1447-53. [PMID: 5935049 DOI: 10.1136/bmj.1.5501.1447] [Cited by in Crossref: 72] [Cited by in F6Publishing: 60] [Article Influence: 1.3] [Reference Citation Analysis]
380 Farmer RG, Brown CH. Ulcerative Proctitis: Course and Prognosis. Gastroenterology 1966;51:219-23. [DOI: 10.1016/s0016-5085(19)34419-1] [Cited by in Crossref: 43] [Cited by in F6Publishing: 27] [Article Influence: 0.8] [Reference Citation Analysis]
381 Watts JM, De Dombal FT, Watkinson G, Goligher JC. Early course of ulcerative colitis. Gut 1966;7:16-31. [PMID: 5906127 DOI: 10.1136/gut.7.1.16] [Cited by in Crossref: 73] [Cited by in F6Publishing: 59] [Article Influence: 1.3] [Reference Citation Analysis]
382 De Dombal FT, Watts JM, Watkinson G, Goligher JC. The early course and prognosis of ulcerative colitis. Proc R Soc Med 1965;58:711-3. [PMID: 5826209 DOI: 10.1177/003591576505800928] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.0] [Reference Citation Analysis]
383 Goligher JC. Treatment of chronic ulcerative colitis. Curr Probl Surg 1965;:1-38. [PMID: 5825010 DOI: 10.1016/s0011-3840(65)80003-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
384 Tandon BN, Mathur AK, Mohapatra LN, Tandon HD, Wig KL. A study of the prevalence and clinical pattern of non-specific ulcerative colitis in northern India. Gut 1965;6:448-53. [PMID: 5294834 DOI: 10.1136/gut.6.5.448] [Cited by in Crossref: 31] [Cited by in F6Publishing: 37] [Article Influence: 0.5] [Reference Citation Analysis]
385 Davidson M, Bloom AA, Kugler MM. Chronic ulcerative colitis of childhood. The Journal of Pediatrics 1965;67:471-90. [DOI: 10.1016/s0022-3476(65)80409-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 0.2] [Reference Citation Analysis]
386 Almy TP, Plaut AG. Ulcerative Colitis: A Report of Progress, Based Upon the Recent Literature. Gastroenterology 1965;49:295-314. [DOI: 10.1016/s0016-5085(19)34543-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.2] [Reference Citation Analysis]
387 Evans JG, Acheson ED. An epidemiological study of ulcerative colitis and regional enteritis in the Oxford area. Gut 1965;6:311-24. [PMID: 5829209 DOI: 10.1136/gut.6.4.311] [Cited by in Crossref: 237] [Cited by in F6Publishing: 263] [Article Influence: 4.2] [Reference Citation Analysis]